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ABSTRACT 
The most remarkable development during a person‟s life takes place in utero. Through 
about 280 days of proliferation and differentiation one single cell is developed into a 
human being. As this is the time when the whole body is formed, it is easy to imagine 
that exposures during this time can have health consequences over the lifespan. Indeed, 
a large number of studies have shown that early exposures, such as low birth weight 
and maternal smoking during pregnancy, influence health later in life, for example the 
risks of hypertension and cardiovascular disease. However, it has been questioned if the 
found associations really reflect causal relationships, or if they are due to genetic or 
environmental confounders. The aim of this thesis was to study how factors during 
prenatal/early life can influence health outcomes over the lifespan, after taking common 
genetic and shared environmental factors into account. The focus lies on 
intergenerational influences of smoking, socio-economic status and foetal growth.  
 
In the first study it is investigated if a change in maternal smoking habits between two 
consecutive pregnancies influences the risk of stillbirth. It was found that women who 
quit smoking between pregnancies have the same risk of stillbirth in their second 
pregnancy as women who never smoked when pregnant. Women, who smoked in one 
of their two pregnancies, had an increased risk of stillbirth in the pregnancy where they 
smoked compared to the pregnancy when they did not smoke. These findings support 
the conclusion of a causal association between maternal smoking during pregnancy and 
stillbirth.  
 
In the second study it is investigated if maternal smoking during pregnancy has a long 
term influence on offspring blood pressure. A small but statistically significant increase 
in systolic and diastolic blood pressure was found in sons whose mothers had smoked 
during pregnancy. This association remained, although not statistically significant, 
within brother pairs. The conclusion is that there might be a long term influence of 
maternal smoking during pregnancy on offspring blood pressure.  
 
In the third study it is investigated if intergenerational social mobility influences the 
risk of hypertension. The results showed a decreased risk of hypertension among twins 
with upward social mobility and indicated an increased risk among twins with 
downward social mobility. The conclusion is that social inequity in hypertension is 
initiated early in life (indicated by parental social status), but modifiable through later 
factors (indicated by adult social status). 
 
In the fourth study it is investigated if the intergenerational influence on birth 
weight/birth length is due to genes or environment. An association between mother‟s 
and offspring‟s size at birth was found within birth weight discordant dizygotic twin 
pairs, but not within monozygotic twin pairs. The conclusion is that the 
intergenerational association in size at birth is due to direct or indirect genetic factors. 
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1 INTRODUCTION 
The most remarkable development during a person‟s life takes place in utero. Through 
about 280 days of proliferation and differentiation one single cell is developed into a 
human being. As this is the time when the body is formed, it is easy to imagine that 
exposures during this time can have health consequences over the lifespan. A large 
number of studies have shown that low birth weight in new-borns is associated with 
increased risk of, for example, hypertension and cardiovascular disease later in life [1]. 
The risk is also increased among those who had a low birth weight without being born 
preterm, i.e. those who were growth restricted. These findings have given rise to the 
Developmental Origin of Health and Disease (DOHaD) hypothesis. It states that 
adverse foetal conditions can alter tissue structure and function, and may thereby 
influence the risk, or even program/predispose for later disease. This hypothesis have 
however been criticized. It has been argued that other factors than foetal conditions can 
explain the association between low birth weight and adult disease [2-4], for example 
genetic or social factors that influence the risk of both low birth weight and 
cardiovascular disease. One way to investigate if an association is due to shared genes 
or common environmental factors (familial factors) is to study if the association 
remains within related individuals, for example within pairs of siblings or twins.  
 
This thesis builds on four studies (Study I-IV) that all are based on Swedish register 
data. The first two deals with adverse effects of maternal smoking during pregnancy. 
Smoking is a known risk factor for several adverse pregnancy outcomes such as 
miscarriage, preterm birth and foetal growth restriction [5]. In Study I, maternal 
smoking during pregnancy is investigated as a cause of stillbirth. Maternal smoking 
during pregnancy has also been suggested to have long term influences on offspring 
health, for example through effects on childhood blood pressure and overweight [6,7]. 
In Study II, it is investigated if maternal smoking during pregnancy has an influence on 
late adolescent offspring blood pressure. Blood pressure is known to track across the 
lifespan [8]; hence adolescents with higher blood pressure are more likely to become 
hypertensive as adults. Smoking in general and maternal smoking during pregnancy in 
particular have over the last decades become strongly socially patterned where women 
from lower socio-economic groups smoke more often than women from higher socio-
economic groups [5]. Health is also often socially patterned. In Sweden, as in other 
countries, there is a social gradient in health where, for most conditions, those with 
lower social status have a higher risk of disease [9]. In the third study of this thesis, 
social mobility (between parent‟s and own socio-economic status group) is studied in 
relation to risk of hypertension. The interest in determinants of birth weight has been 
renewed in the light of the DOHaD hypothesis. Social status is related to birth weight 
and there is also a known association between parent‟s and offspring‟s size at birth. In 
the fourth study this intergenerational association in size at birth is investigated among 
female twins and their offspring, aiming to separate genetic and environmental 
influences.  
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2 BACKGROUND 
 
2.1 FOETAL GROWTH 
Appropriate foetal growth is important for health in both the short and the long 
perspective. Infants, who fail to reach their full growth potential, face increased risks of 
perinatal morbidity and mortality [10]. Adults, who were growth restricted at birth, face 
increased risks of hypertension, diabetes and cardiovascular disease later in life [11]. 
Growth restricted infants are often born preterm, which is a risk factor in itself. In this 
thesis, the focus lies on growth restriction; therefore risks of preterm birth will not be 
further discussed. Before we go into determinants and consequences of intrauterine 
growth restriction, some aspects of normal pregnancy and some definitions need to be 
clarified.   
Pregnancy duration 
Usually, it is not possible to know the exact date of conception. Therefore, information 
about the first day of the last menstrual period (date of LMP) is used to estimate 
pregnancy duration (that date, plus seven days, minus three months gives the expected 
date of delivery). This gives a pregnancy duration of 40 weeks or about 280 days [12]. 
Pregnancy duration can, more accurately, be estimated through early ultrasound 
measurements of foetal dimensions (usually the biparietal diameter or the crown-rump 
length). This has been done in almost all pregnancies in Sweden since the 1990‟s [13]. 
A term birth takes place between the 37
th
 and 42
nd
 week of gestation [12]. An infant 
born before the 37
th
 week of gestation is said to be preterm and if born after 42 
completed weeks the infant is said to be post-term [12]. To match the current viability 
limits, the cut off between late miscarriage and preterm birth has been set to 22 
completed weeks of gestation.  
Birth weight – a proxy for foetal growth 
Birth weight is the result of both gestational age and foetal growth. Hence, a new-born 
can have low birth weight because of (1) preterm birth, (2) restricted foetal growth or 
(3) both. Normal birth weight (±2SD) for a term infant (40 weeks of gestation) in 
Sweden is between 2700 and 4400 g [14,15]. Low birth weight is defined as a weight 
below 2500 g. Low birth weight infants have increased risks of infant morbidity and 
mortality, and these risks increase with a reduction in birth weight [16]. In many 
epidemiological studies, birth weight is used as a proxy for foetal growth, as 
information on birth weight (but not gestational age) is often available. However, it 
only provides a measurement of one single time point and does not take differences in 
gestational age into account. To assess foetal growth and foetal growth restriction, 
repeated measurements of foetal size are required. Most often, this information is not 
available; instead small for gestational age (SGA) is used as a proxy for intrauterine 
growth restriction (IUGR). A foetus or infant is classified as SGA if the estimated 
foetal weight/birth weight is below a certain cut off, e.g. two standard deviations or the 
10
th
 percentile of the mean value for the specific gestational week [16]. Among infants 
diagnosed as SGA, there will be those who have suffered from foetal growth 
restriction, but there will also be some who are just constitutionally small [17]. 
Intrauterine growth restriction is defined as a reduction in growth rate that prevents the  
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foetus to reach his or her full genetic growth potential [10]. Most IUGR infants will be 
classified as SGA, but some can also be born with appropriate birth weight for 
gestational age (AGA). These and other definitions are summarized in Table 1.  
Determinants of intrauterine growth restriction (IUGR) 
Birth weight is influenced by both genetic and environmental factors. Women and men 
who themselves were heavy at birth are more likely to be tall and heavy as adults and to 
have larger offspring than smaller parents [16]. Generally, these associations are 
stronger on the matrilineal side [16]. The risk of having an SGA infant is increased if 
the mother was born SGA herself, if her sister had an SGA infant, or to a lesser extent 
if her brother had an SGA infant [18]. There are many different causes to foetal growth 
restriction. In western countries, placental insufficiency and maternal smoking have 
been pointed out as the most important factors [10,16]. In developing countries, 
insufficient maternal nutrition and malaria play a larger role [10]. Determinants of 
IUGR can be divided into maternal, placental and foetal factors (Table 2 [10,16,17,19-
21]). 
Maternal factors 
Short stature, low pre-pregnancy weight and poor gestational weight gain have all been 
associated with increased risk of IUGR [19]. In Sweden, there has been a trend of 
increasing mean birth weight during the last decades, which has been suggested to 
partly be due to a concurrent increase in BMI among pregnant women [22]. At the 
same time, there has been a slight decrease in infants with birth weight between 1500 
and 2499 g [22]. Probably, the increase in mean birth weight is also due to a large 
decrease in maternal smoking during pregnancy. Cigarette smoking is causally related 
to foetal growth and decrease birth weight by around 135-300 g [5,21]. Alcohol 
consumption and illicit drugs also affect foetal growth negatively, as well as some 
prescribed drugs (antimetabolites, anticoagulants, anticonvulsants) [20]. High altitude 
influence foetal growth through hypoxia and the same influence can be seen in women 
with severe lung disease, cardiac disease or severe anaemia [10].  
Table 1. Definition of measures used to assess foetal growth. 
Low birth weight Birth weight below 2500 g.  
Macrosomia Birth weight above 4500 g.  
Small for gestational age (SGA)* Birth weight below -2SD of the expected 
birth weight given the gestational age. 
Appropriate for gestational age (AGA) Birth weight within ±2SD of the expected 
birth weight given the gestational age. 
Large for gestational age (LGA) Birth weight above +2SD of the expected 
birth weight given the gestational age.  
Intrauterine growth restriction (IUGR) A failure to reach the full genetic growth 
potential, seen as a deviation from the own 
growth curve.  
*To determine SGA, AGA and LGA birth weights are compared towards a standard 
growth curve for the population. SGA can also be defined using other cut offs, such as 
a birth weight below the 10
th
 percentile. 
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Other medical conditions associated with IUGR are hypertension which increases the 
incidence 2-3 fold [20]. Hypertension can be further superimposed by preeclampsia, 
which is thought to be caused by inappropriate placentation and lead to insufficient 
nutritional supply for the foetus. Renal disease is associated with both hypertension and 
preeclampsia. Diabetes is often associated with macrosomia. Paradoxically there is also 
an association with IUGR, which might be due to damages in the microcirculation or 
common genetic causes [4,20]. Autoimmune diseases, such as systemic lupus 
erythematosus (SLE), increase the risk of foetal growth restriction eight-fold [20]. 
There is a large overlap between several of the factors influencing foetal growth 
restriction [19]. Socio-economic status has been suggested to influence foetal growth 
indirectly [19]. Further, ethnicity might at least partly have indirect influences. There 
are large differences in mean birth weight between different ethnic groups. For 
example, in India, mean birth weight is 700 g lower than in many western countries 
[23]. However, this difference can largely be explained by small maternal size and 
maternal under nutrition. A study of first and second generation Indian immigrants to 
the UK showed that women born in the UK gave birth to significantly larger infants 
than women born in India [24]. Ethnicity is often strongly linked to socio-economic 
status; it has been shown that African born black women in USA do not have the same 
increase in risk of IUGR as American born black women, suggesting an effect of social 
status rather than ethnicity [17]. Assisted reproductive techniques (ART) have also 
been associated with increased risk of IUGR [25], suggesting that very early 
disturbances of the embryo‟s environment can influence foetal growth.  
Table 2. Maternal, placental and foetal factors associated with foetal growth and 
IUGR. 
Maternal 
Demographic Nutritional  Drugs 
Maternal height, weight Severe caloric restriction Cigarette smoking  
Maternal birth weight Medical conditions Alcohol consumption 
Gestational weight gain  Preeclampsia Illicit drugs 
Inter-pregnancy interval Hypertension Some prescribed drugs  
Parity Renal disease Other 
Ethnic group Diabetes Reproductive technology 
Maternal age Autoimmune diseases Previous SGA infant 
Environmental Hypoxemia  Socio-economic position 
High altitude   
Placental Foetal  
Structural Demographic Congenital malformations 
Abnormal placentation Sex Cardiovascular defects 
Placenta praevia Multiple gestations Skeletal dysplasia e.g. 
Chorioangioma Genetic Intrauterine infections 
Velamentous insertion       Parent‟s size Viral (CMV, Rubella) 
Hormonal Chromosomal abnormality Bacterial (syphilis) 
Insulin, steroids, GH etc. GH, GHr mutation Protozoal (malaria) 
CMV=Cytomegalovirus. GH=Growth Hormone r=receptor.  
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Placental factors 
Naturally, foetal growth is strongly dependent on placental function. Structural 
placental abnormalities can influence foetal growth negatively, e.g. if the placenta is 
small or affected by infarctions or lesions [17,20,21]. Placenta praevia, larger 
chorioangiomas (benign blood vessel tumours in the placenta) and a velamentous 
umbilical cord insertion (umbilical cord inserted in the foetal membranes instead of the 
placental mass) can also impair foetal growth [17,20]. The most important factor is the 
abnormal placentation often seen in pregnancies with preeclampsia, foetal growth 
restriction, placental abruption and stillbirth. In such pregnancies, there is insufficient 
cytotrophoblast invasion and incomplete reformation of the spiral arteries, leading to 
inadequate perfusion of the placenta, local placental hypoxia and impaired foetal 
growth [10,26]. The placenta also has endocrine functions. Alterations in hormone 
levels (insulin, steroids, growth hormone, placental lactogen) has been suggested to 
affect foetal growth [17].  
Foetal factors 
Male foetuses grow faster than female foetuses. In developed countries the sex 
difference in mean birth weight has been estimated to be 126 g [16]. Multiple gestation 
is a clear risk factor for IUGR, twins and triplets are significantly smaller than 
singletons at birth. Chromosomal abnormalities, congenital malformations and genetic 
disorders can cause foetal growth restriction [17]. Further, viral, bacterial and protozoal 
intrauterine infections can pose a threat to normal foetal growth, e.g. rubella, 
cytomegalovirus, herpes simplex, HIV, syphilis and malaria and toxoplasma [10,17].  
 
Regulation of foetal growth 
Some of the described factors that influence foetal growth are due to pathology, while 
some are due to physiology. Non-genetic and non-pathological maternal factors that 
restrict foetal growth can be referred to as maternal constraint [27]. This operates to 
some extent in all pregnancies through e.g. maternal size, parity, age and nutrition [27]. 
One of the first, and often cited, publications demonstrating maternal constraint was 
Walton and Hammond‟s cross-breeding experiments with Shire horses (at least 170 cm 
tall) and Shetland ponies (around 100 cm tall) from 1938 [28]. They found that the 
reciprocal crossbred fouls had the same size at birth as pure bred foals of the mare‟s 
breed [28]. Clearly, there was a large influence of maternal size. From an evolutionary 
perspective, mammals have to balance between the foetus and the mother‟s nutritional 
needs [27]. Further, the foetus cannot be larger than that it permits vaginal delivery 
[27]. Before the 16
th
 week of gestation there is very little variation in foetal size and the 
growth is mainly determined by the foetal genes [29], but thereafter environmental and 
hormonal factors become increasingly important.  
The most important hormone system for foetal and placental growth throughout 
gestation is the insulin-like-growth factor (IGF) system. This system includes IGF-1 
and IGF-2 that, through the IGF-1 receptor has mitogenic and antiapoptotic effects 
[30]. The IGF-2 receptor has a regulatory function that leads to decreased IGF-2 levels. 
Both IGF-1 and IGF-2 are expressed throughout pregnancy. In embryonic development 
IGF-2 is most important, while the importance of IGF-1 increase later in gestation [30]. 
It has been found that foetal and cord serum concentrations of IGF-1 correlates with 
birth weight. Levels are decreased in IUGR infants and increased in LGA infants [30]. 
Furthermore, infants with IUGR have increased levels of IGF-binding proteins (there 
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are six such proteins). Knock-out studies in mice have showed that a disruption of Igf1, 
Igf2 or Igf1-receptor alleles results in foetal growth restriction [30]. Further, an 
overexpression of IGF-2, due to disruption of Igf2-receptor causes foetal overgrowth 
[30]. The Igf2 and the Igf2-receptor genes are imprinted, i.e. parent of origin 
determines which alleles that will be expressed [30]. Imprinting of genes is thought to 
have evolved as a conflict between the paternal genome, that promotes growth for his 
offspring, and the maternal genome, that wants to regulate growth [31]. Genes are 
imprinted through epigenetic mechanisms [32]. The Igf2 gene, that promotes growth, is 
paternally imprinted, and the Igf2-receptor gene that regulates growth is maternally 
imprinted [30]. Changes in normal imprinting have been linked to both IUGR and 
overgrowth in humans. One of the clinical presentations in Beckwith-Wiedemann 
syndrome is overgrowth. This syndrome can be caused by different genetic or 
epigenetic changes in a specific chromosomal region, which leads to upregulation of 
paternally imprinted genes and downregulation of maternally expressed genes [30,33]. 
In Silver-Russel syndrome, which presents with severe intrauterine growth restriction, 
two regions containing imprinted genes have been shown to have duplicated maternal 
copies [30,33].  
Why foetal growth matters 
Low birth weight influences health outcomes over the lifespan (Table 3). On short 
term, growth restriction is an important risk factor for stillbirth, neonatal mortality and 
morbidity [10]. Although a majority of growth restricted children have a catch up 
growth, around 10% have continued poor growth and might be shorter than expected as 
adults [10]. This can be a larger problem in low income countries with higher demands 
on physical work abilities. Intrauterine growth restriction has also been associated with 
increased risks of sudden infant death syndrome (SIDS) and cerebral palsy, small 
decreases in IQ, learning disabilities, and impaired airway function [10]. Decreases in 
IQ and learning problems can influence the child‟s educational attainment and possible 
life chances [34]. Low birth weight and IUGR is also associated with several adverse 
health outcomes in adulthood, this has given rise to the Developmental Origins of 
Health and Disease hypothesis which will be further discussed in the next section. 
 
Table 3. Short and long term risks associated with low birth weight and IUGR.  
Perinatal outcomes Childhood outcomes Adult outcomes 
Mortality Mortality Mortality 
Stillbirth  SIDS Death from CVD 
Neonatal death   
Morbidity  Morbidity Morbidity 
Hypoglycaemia Continued poor growth CVD 
Hypothermia Small decrease in IQ Hypertension  
Polycythaemia Cerebral palsy Diabetes type 2 
Severe depression at birth Learning disabilities Preeclampsia  
Infection Impaired airway function Osteoporosis, etc. 
SIDS=Sudden Infant Death Syndrome CVD=Cardiovascular disease 
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2.2 DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE  
The hypothesis 
The first to propose that early life deprivation could predispose to coronary heart 
disease was David Barker and Clive Osmond in 1986 [35]. Although, this was not a 
completely new idea [36,37], there was a new focus on the influence of nutrition. Clive 
and Osmond found an association between low birth weight and mortality from 
coronary heart disease. With time, these findings have been replicated numerous times 
and in many different populations [1,38]. Associations have also been shown between 
low birth weight and other outcomes, including stroke, hypertension and type 2 
diabetes [38]. Further, the importance of postnatal growth has been demonstrated, as 
the highest risks are seen among those who were small at birth but large in childhood 
and adulthood [38]. The findings relating low birth weight/poor foetal growth to later 
disease has evolved into the Developmental Origins of Health and Disease (DOHaD) 
hypothesis, described by Professor Barker as follows: “The foetal origins hypothesis 
proposes that coronary heart disease, type 2 diabetes, stroke and hypertension originate 
in developmental plasticity, in response to under nutrition during foetal life and 
infancy” [38]. 
Developmental plasticity or foetal programming 
According to the DOHaD hypothesis these diseases originate in developmental 
plasticity or foetal programming. That is, a process in which a stimulus or insult during 
a critical or sensitive period of development has lasting effects on the structure or 
function of the body [11]. This process could be of advantage for the individual if the 
stimulus correctly predicts the extra uterine environment and leads to adaptions suitable 
for this milieu, a so called predictive adaptive response [39]. It has been suggested that 
poor intrauterine nutrition due to maternal starvation could lead to such as response; 
maternal under nutrition is then a signal that predicts a harsh environment, the foetus 
adapts by a smaller body size and insulin resistance which could be an advantage in a 
food deprived environment [38,40]. However, if the poor intrauterine nutrition is due 
to, for example maternal disease or eating disorders, there will be a mismatch between 
the predicted environment and the actual environment the infant is born into. The 
adaptions suitable for a harsh environment will then be a disadvantage in a milieu 
where food is abundant, and this leads to a predisposition for later disease [38,40].  
 
The finding that risks of cardiovascular and metabolic diseases are modified by 
postnatal growth supports this theory, i.e. those who are born small and become 
overweight later in life have the highest risk of disease [38]. Another example comes 
from “natural experiments” of starvation. People who were born during or after the 
Dutch Hunger Winter had decreased glucose tolerance and evidence of insulin 
resistance at age 50 [41], while no such effects were seen in people born during or after 
the Leningrad siege [42]. In Holland the food shortage was immediately reversed after 
liberation from the German occupation, while in Russia the food shortage remained 
even after the war.  
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Possible mechanisms  
Results from studies in several species have supported the DOHaD hypothesis. The 
inverse association between birth weight and both blood pressure and insulin resistance 
has, for example, also been found in guinea pigs [43]. Further, manipulations of 
maternal diet and glucocorticoid administration during sensitive periods of gestation in 
mouse, rat, guinea pig, sheep and pig have been shown to cause permanent changes in 
the offspring‟s physiology [43]. These changes include insulin resistance, altered 
appetite regulation, altered hypothalamic-pituitary-adrenal axis (HPA) function and 
endothelial dysfunction, which can be seen as changes in programmed set points of 
physiological systems [1,43]. There are also structural changes in organ development 
and growth, for example reduced nephron number in the kidneys, reduced β-cell mass 
in the pancreas, increased fat mass vs. lean body mass and reduction in skeletal muscle 
fibres [43,44]. Several of the proposed mechanisms are thought to be due to epigenetic 
changes, i.e. an altered gene expression without a change in the gene sequence [44]. 
Effects of maternal undernutrition and exposure to glucocorticoids have been suggested 
to have similar mechanisms, as undernutrition reduces the activity of the enzyme 11β-
hydroxysteroid dehydrogenase, which deactivates cortisol [43]. In humans, low birth 
weight infants have increased cortisol concentrations in umbilical cord blood [45] and 
increased cortisol secretion also later in life [46]. Reduced number of glomeruli in the 
kidneys is thought to accelerate the decline in renal function that comes with ageing 
and predispose to hypertension [44]. Figure 1 shows a simplified overview of the 
mechanisms underlying the DOHaD hypothesis. 
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Critique or alternative explanations 
The DOHaD hypothesis has been criticised on a number of points. It has been 
questioned if the association between foetal growth and adult disease is important 
today, as many studies used historical data. Further, concerns about socio-economic 
and genetic confounding have been expressed. Both low birth weight and 
cardiovascular disease are more common in low socio-economic groups [47,48] and 
genetic factors could also influence both foetal growth and disease development, for 
example genes predisposing to type 2 diabetes [4]. It has also been questioned how 
important these associations are, even if they are causal [2]. For example, in a large 
meta-analysis a one kilo decrease in birth weight was only associated with very small 
(less than 1 mm Hg) increase in blood pressure [49]. 
  
In response to this critique, it has been argued that many countries in the world still 
have similar conditions as industrialized countries had one hundred years ago. 
Considering the rapid changes in these societies in terms of diet and food availability, 
even larger effects of low birth weight could be expected [50]. Further, associations 
between low birth weight and adult disease remain within all socioeconomic strata and 
through the whole range of birth weights [51]. Studies within birth weight discordant 
twin pairs were hoped to provide some insight in underlying mechanisms, however 
they have yielded mixed results. The association between low birth weight and 
hypertension remains within monozygotic twins, suggesting an influence of foetal 
programming [52].  While the association between low birth weight and stroke and 
coronary heart disease does not remain within monozygotic twin pairs, suggesting that 
the association is due to genetic confounding [53]. With respect to type 2 diabetes, one 
study found evidence of foetal programming [54], while results from another study 
suggested that the association was confounded by genetic factors [55]. Although the 
influence on blood pressure may be very small, larger effects on hypertension risk have 
been reported. For example, in an American study of more than 22 000 men, the effect 
on blood pressure was less than 1 mm Hg per kilogram increase in birth weight, but the 
association between birth weight and treated hypertension was stronger with more than 
30% difference in prevalence across the birth weight range [56].  
 
It can also be questioned if the changes seen in growth restricted individuals really are 
due to a mismatched predictive adaptive response. Developmental response to the 
environment can be without any evolutionary significance [40]. The growth restricted 
foetus can relocate resources to prioritise some organs e.g. the brain on the expense of 
others, such as the kidneys [40]. This might be advantageous for short term survival, 
but increase the risk of disease on long term. Similarly, increased growth in childhood 
(catch up growth) might be beneficial on short term, but have costs in terms of altered 
hormone levels and increased demands on suboptimal developed organs, which in the 
long run increase the risk of disease [38].  
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2.3 MATERNAL SMOKING DURING PREGNANCY 
How common is it to smoke during pregnancy? 
Since 1983 there has been a steady decrease in maternal smoking in early pregnancy 
(self-reported at first visit to antenatal care) from 31.4% in 1983 to 6.5% in 2010 
(Figure 2).  
 
Although this is a very positive development, there are still subgroups where the 
prevalence of maternal smoking is high. Among teenage mothers smoking is more 
common (27%) than in other age groups [57]. Furthermore, the prevalence of smoking 
during pregnancy shows large variations between different areas. In 2006, there were 
still some municipalities with a prevalence around 20-30%, while only 0-2% of women 
in other areas smoked during pregnancy [57]. Smoking in general and maternal 
smoking during pregnancy in particular are strongly related to socio-economic status 
and these differences have increased over time [58]. Table 4 shows the three 
municipalities in Stockholm County with the highest and the lowest prevalence of 
parental smoking, respectively. The three areas with the lowest smoking prevalence are 
all among the ten wealthiest municipalities in Sweden [59]. There is also a strong 
association with education. In Sweden, 3% of high educated women (≥15 years) 
smoked during pregnancy in 1997, compared to 34% among low educated women (≤9 
years) [5]. In the 1960‟s, when the adverse effects of smoking were relatively unknown 
in society, 97% of smoking women continued to smoke during pregnancy [58]. Today, 
most pregnant women are aware of risks for their foetus and 20-40% quit smoking in 
early pregnancy [5]. Most quit already before the first visit to antenatal care, some quit 
later in pregnancy, and among those who continue to smoke about 50% report that they 
have cut down the amount smoked [5,60]. Risk factors for continued smoking during 
pregnancy are severity of addiction (amount smoked and age at onset of smoking), low 
maternal education, multiparity, exposure to passive smoking at home and not 
cohabiting with the infant‟s father [61]. Partner smoking is also a major risk factor for 
taking up smoking after delivery [60].  
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Data source: National Board of Health and Welfare, 2012 
Figure 2. Prevalence of maternal smoking in early pregnancy in 
Sweden 1983-2010 
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Adverse effects of smoking during pregnancy 
Smoking during pregnancy has been associated with several adverse pregnancy 
outcomes and some studies also suggest long term influences on offspring‟s health 
[5,62]. Smoking during pregnancy is causally related to foetal growth restriction; 
smoking of 10 cigarettes per day has been associated with a 200 g reduction in birth 
weight [5]. Further, there is a dose-response relationship and smoking cessation in early 
pregnancy has been shown to increase birth weight [63]. Potential mechanisms for this 
are chronic foetal hypoxemia due to increased levels of carbon monoxide haemoglobin 
and reduced uterine and placental blood flow due to increased vascular resistance [5]. 
Smoking is also associated with increased risks of placenta complications such as 
placental abruption (premature separation of the placenta from the uterine wall) and 
placenta praevia (when the placenta partly or completely covers the internal os), which 
both are potential causes of foetal and maternal death [5]. Underlying mechanisms for 
placental abruption has been suggested to be degenerative and inflammatory alterations 
in the placenta, decreased levels of ascorbic acid, which is important for collagen 
synthesis, and increased risk of premature rupture of the membranes in smoking 
mothers [5]. Foetal growth restriction and placental complications have been shown to 
explain the increased risk of stillbirth seen in mothers who smoke during pregnancy [5]. 
Further, maternal smoking during pregnancy has been associated with increased risks 
of infertility (defined as inability to conceive after twelve months of unprotected 
intercourse), ectopic pregnancy, spontaneous abortion, preterm delivery, neonatal 
mortality (first week of life), oro facial clefts and sudden infant death syndrome (SIDS) 
[5]. Paradoxically, smoking during pregnancy is inversely associated with preeclampsia 
risk [5].  
Women exposed to passive smoking during pregnancy also have increased risks of 
adverse pregnancy outcomes, although risks are generally lower than in active smokers 
[64]. Further, smokeless tobacco such as the Swedish moist snuff (“snus”) is associated 
with both preterm birth and stillbirth [65,66]. In 2006, the prevalence of oral moist 
snuff (“snus”) use among pregnant women ranged between 0.5 and 6.9% in different 
Swedish counties, with an average of 1.4% [57].  
Table 4. Smoking prevalence among parents in the three municipalities in 
Stockholm County where the prevalence was highest and lowest, respectively in 
2006. 
 Parental smoking (%) 
 In pregnancy When the child is 0-4 
weeks 
When the child is 8 month 
Municipality Week 8-12 Mother Father Mother Father 
Norrtälje 12.5 9.8 14.1 12.2 13.9 
Nynäshamn 11.0 7.2 11.8 7.7 11.0 
Södertälje 9.4 7.1 19.7 9.8 18.7 
Danderyd 1.0 0.8 4.8 0.0* 4.8* 
Vaxholm 1.8 1.2 3.7 2.6 5.2 
Lidingö 1.9* 0.2 5.1 0.6 5.3 
*Missing data in more than 20%. 
Adapted from “Tobaksvanor bland gravida och spädbarnsföräldrar 2006” [57]. 
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Are there long term effects of maternal smoking during pregnancy? 
While it is very clear that smoking threatens the health of the foetus and the new-born, 
it is much less clear whether exposure to smoking in utero also has long term effects on 
health. In the light of the DOHaD hypothesis, several studies have investigated if 
smoking during pregnancy has long term influences on, for example offspring blood 
pressure, obesity, type 2 diabetes and neurobehavioral outcomes [62]. The proposed 
mechanisms are largely the same as outlined for the DOHaD hypothesis, with the 
addition that nicotine itself and other components in cigarettes (carbon monoxide, 
cadmium, and additives) can have detrimental long term effects on the individual [62]. 
Several experimental studies on animals exposed to nicotine during pregnancy have 
also shown effects in offspring, such as elevated blood pressure, loss of β-cell mass in 
the pancreas and impaired insulin sensitivity in peripheral tissues [67]. Although 
several studies on humans have shown associations with in utero exposure to smoking 
and later disease [6,68], it is difficult to determine whether these associations are 
causal. Power et al. found associations with in utero exposure to smoking and adult 
BMI, waist circumference, blood pressure, HbA1c (a measure of long time blood sugar 
levels) and triglycerides (blood lipids), but after adjustment for postnatal influences 
only BMI and waist circumference remained significant [69]. It has also been shown 
that the association with smoking during pregnancy and both offspring BMI and IQ can 
be attributed to familial confounding [70,71]. Studies investigating maternal smoking 
and offspring blood pressure have yielded very mixed results. About half of the studies 
have reported positive associations, while the other half have reported null findings or 
attenuations towards the null after adjustments. In their review, Bakker and Jaddoe 
conclude that further studies that account for potential confounders are needed [62]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   13 
0
1
2
3
4
5
6
7
8
R
a
te
/1
0
0
0
 b
ir
th
s 
Data source: National Board of Health and Welfare, 2012 
Figure 3. Stillbirth in Sweden 1973-2010 
2.4 STILLBIRTH 
Stillbirth causes great distress and grief among afflicted parents. Around 3 million 
stillbirths have been estimated to occur each year and 98% of them occur in low and 
middle income countries [72]. There are different definitions of stillbirth ranging from 
foetal death from the 20
th
 to the 28
th
 gestational week or from a foetal weight of 350-
1000 g [73]. In Sweden, stillbirth is now defined as foetal death after at least 22 
completed weeks of gestation (before 2008, the definition was 28 completed weeks of 
gestation) [74]. The incidence of stillbirth in Sweden is 3-4 per 1000 births and has 
been rather constant during the last thirty years (Figure 3).  
 
In a recent meta-analysis, maternal overweight/obesity, maternal smoking, high 
maternal age, primiparity, a small for gestational age foetus, placental abruption and 
pre-existing maternal diabetes/hypertension were pointed out as the most important risk 
factors of stillbirth in high income countries [75]. Overweight/obesity combined has 
been estimated to increase the odds of stillbirth by 28-58%. Maternal smoking has been 
associated with at least 40% increase in odds and high maternal age (>35 years) also 
increase risk of stillbirth, especially in primiparous women [75]. Other risk factors of 
stillbirth are; low socio-economic status [76], low maternal education [77], stillbirth or 
IUGR in a previous pregnancy [78], infections, congenital malformations/genetic 
abnormalities, multiple births, placental and umbilical cord complications, maternal 
injury and other maternal medical conditions, such as lupus and cholestasis in 
pregnancy  [73,79,80]. Despite this, the cause remains unknown  in at least 10-15% of 
stillbirths [74]. Bendon has described how complex chains of risk factors can lead to 
stillbirth and suggests three common death mechanisms; hydrops, asphyxia and shock 
[81]. To reduce stillbirth rates, it has been suggested that risk factors such as smoking, 
overweight and high maternal age should be reduced in the pregnant population and 
supervision of pregnancies complicated by other risk factors should be increased [75]. 
Primary prevention of smoking has been pointed out as the most efficient way to 
reduce smoking during pregnancy, while effective tools to reduce other risk factors, 
such as overweight and high maternal age are lacking [82].  
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2.5 HYPERTENSION 
An adequate blood pressure is necessary to sustain the circulation and perfusion of 
organs and tissues in the body. As the name says, blood pressure is the pressure exerted 
by circulating blood on the inner walls of the arteries. (There is a pressure in the veins 
too, but it is the arterial blood pressure that is measured). Both blood pressure and 
blood flow is generated by the heart and is hence pulsatile. Maximum blood pressure is 
reached during systole – when the heart contracts and pumps out blood in the 
circulation, this is the systolic blood pressure. The lowest blood pressure is reached 
during diastole – when the heart relaxes and is filled with blood, this is the diastolic 
blood pressure. The difference between systolic and diastolic blood pressure is called 
pulse pressure [83]. The body regulates the blood pressure through both central and 
peripheral mechanisms, e.g. baroreceptors, sympathetic innervation and through 
hormones (epinephrine, norepinephrine, renin-angiotensin-aldosterone axis) [83]. 
Blood pressure can be increase through increased total peripheral resistance, or through 
increased cardiac output [83]. With age, blood vessels often become stiffer due to 
atherosclerosis. This leads to a decreased blood vessel compliance and increased 
peripheral resistance which can result in hypertension [83].  
 
Normal blood pressure has been defined as below 120 mm Hg systolic and 80 mm Hg 
diastolic [84]. Hypertension is defined as a systolic blood pressure (SBP) above 140 
mm Hg and/or a diastolic blood pressure (DBP) above 90 mm Hg [84]. Repeated 
measurements are usually required for the diagnosis. Often, hypertension gives no 
symptoms in itself; although very high levels can cause headache, dizziness, irritability 
and palpitations [85]. The interest in finding people with high blood pressure lies 
instead in prevention of cardiovascular disease. Hypertension is a risk factor for 
myocardial infarction, stroke, angina pectoris, claudicatio intermittens and 
nephrosclerosis [85]. As previously mentioned, hypertension during pregnancy is also 
related to adverse outcomes for the foetus, such as IUGR and stillbirth, especially when 
the increased blood pressure is superimposed by preeclampsia [86].   
 
In 95% of cases, there is no known cause to the increased blood pressure, this is then 
referred to as primary or essential hypertension. Risk factors for essential hypertension 
are high age, overweight/obesity (especially abdominal), high alcohol consumption, 
stress, high salt consumption, low socio-economic status and hereditary factors [85]. As 
mentioned earlier, developmental factors are also associated with increased blood 
pressure, such as IUGR, preterm birth and in some studies maternal smoking during 
pregnancy [87,88].  
 
Hypertension is a very common condition; the prevalence in the adult (>20 years) 
Swedish population has been estimated to 27% [89]. In the population over 70 years 
more than 50% have hypertension [85]. Blood pressure has been shown to “track” over 
the lifespan, i.e. there is a correlation between childhood and adult blood pressure 
[90,91]. Therefore, childhood blood pressure can be a predictor of adult blood pressure 
and risk of hypertension. 
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2.6 LIFE COURSE PERSPECTIVE 
It is known that adult lifestyle factors (e.g. smoking, alcohol, physical activity, diet) and 
other adult risk factors (e.g. high blood pressure, high blood lipids and glucose) are 
important for disease development. We have also seen that early development is 
important for later disease (DOHaD). Life course epidemiology aims to bridge over 
these different perspectives; developmental and adult risk factors, as well as integrating 
biological and social risk processes within and over generations [92]. The life course 
perspective is often applied in research regarding socio-economic influences on health. 
There are different theoretical models used in life course epidemiology to explain how 
factors across the lifespan can influence health, e.g. the critical period model and the 
accumulation model. These are not competing hypothesis, but rather related and able to 
operate at the same time [93].  
Critical/Sensitive period model 
The critical period model assumes that irreversible changes in a body, that were 
induced during a specific period of development, is important for future health, hence 
timing of exposure is important [94]. This model has also been called biological 
programming or latency model and underlies the DOHaD hypothesis [94]. A critical 
period has been defined as a time window during which an exposure can have 
protective or adverse effects on development and subsequent health; outside this time 
window the exposure is not associated with disease risk [94]. Usually critical periods 
take place during foetal development or other times of rapid growth and differentiation. 
An example of a critical period is limb development in pregnancy week 3-8, when 
exposure to thalidomide causes limb malformations; exposure outside of this critical 
period does not cause malformations [94]. A sensitive period is a time window where 
an exposure has a stronger influence on development and subsequent health than it has 
at other time points [92].  
Social mobility model 
The social mobility model can also be seen as a critical period model with later effect 
modification [95]. For example, the influence of social factors during early life 
(critical/sensitive period) might be modified by later social factors that depend on social 
mobility. The focus lies on change in socio-economic status (upward or downward 
mobile groups) and later disease. Social mobility can be assessed either during a 
person‟s own working life (intragenerational) or between generations 
(intergenerational).  
Accumulation model 
In contrast to the critical/sensitive period and the social mobility models, the 
accumulation model assumes that cumulative exposures over the life course influence 
the risk of later disease irrespective of their timing [96]. According to the accumulation 
model, the effect of, for example, low socio-economic status in childhood and in 
adulthood would be the same. There are different types of accumulation models [96]. 
First, exposures can be separate and independent of each other. Second, they can cluster 
together, often in socially patterned ways. Third, exposures can be linked to one 
another in such a way that one exposure leads to the next; a chain of risk model. Fourth, 
if only the last exposure in the chain of risk causes the disease, this last exposure can be 
said to have a trigger effect. 
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2.7 SOCIAL STATUS AND SOCIO-ECONOMIC INEQUITIES 
Socio-economic status (SES) can be of interest in research for descriptive purposes, 
when investigating how health effects of social differences is mediated, or as a 
confounder. Low socio-economic status is associated with increased mortality and 
morbidity from a large number of diseases, including hypertension, cardiovascular 
disease and adverse pregnancy outcomes such as IUGR and stillbirth [97]. In Sweden, 
there is for example a five year difference in life expectancy between those with the 
lowest and those with the highest education [9]. The social gradient in health is 
apparent over the whole range of social groups; it has even been shown that men with a 
doctoral degree live longer than men with “just” a high university degree [98]. Health 
differences that are perceived as unjust, unnecessary and avoidable are referred to as 
social inequity. Differences that are not perceived as unjust, for example a higher 
mortality in old people compared to young people, are referred to as social inequality 
[99].  
What causes social inequities in health? 
To a large part, social differences in health are caused by social differences in 
determinants of health [9]. Such determinants are life-style factors, access to health 
care, area of living, social network, work conditions, stress etc. Around 30-50% of 
socio-economic differences in mortality have been explained by health related life-style 
factors [9]. In one study, this proportion was even higher; 72%, out of which smoking 
alone explained 35% [100]. Other important life-style factors are physical activity, diet 
and alcohol consumption [9]. Psychosocial factors that influence these life-style factors 
are also of great importance [101]. Further, there can also be some degree of reverse 
causation, where healthy people are more likely to experience upward social mobility 
and vice versa.  
Operationalization of social status 
Social status is often operationalized through education, occupation or income [102]. 
These measurements are strongly correlated but not completely interchangeable [102]. 
Education captures more of knowledge related assets [102]. It is usually completed in 
young adulthood and contains the transition from the parents status to the own adult 
status. Thereby, education reflects both childhood and young adult social status. 
Further, it is a strong predictor of occupation and income and might also capture 
cognitive abilities. Advantages with education as a measure of SES are that it is easy to 
measure and valid over different ages and working circumstances in a person‟s life. A 
disadvantage is that there can be cohort effects, where a certain length of education 
means different things in different age groups, in women or among people who have 
studied abroad. Income is a more direct measure of material resources. Money in itself 
is not likely to be related to health, but rather what you can buy for money in terms of 
housing, food and services. It might also influence self-esteem and social participation. 
Money is considered the best indicator of material living standards; however it might 
be sensitive information with lower response rates in questionnaires and it can fluctuate 
over time [102]. Occupation is related to both prestige and income and reflects a 
person‟s place in society [102]. Occupation is strongly related to both education and 
income. It also reflects social privileges such as access to health care or education, 
social networks, work stress, psychosocial milieu, toxic environments and physical 
   17 
79
80
81
82
83
84
85
86
Norrtälje Nynäshamn Södertälje Danderyd Vaxholm Lidingö
Years 
Figure 4. Life expectancy for a girl born 2007-11 
demands [102]. Information about occupation is often easily available, but it can 
change over the life course and people who are outside the work force, such as 
unemployed, students, house-wives and retired citizens are often excluded. There is not 
one measure of social status that always is preferable [102]. As said, they are strongly 
related but at the same time they capture somewhat different aspects of status or 
position in society.  
 
There are also correlations across generations, for example in educational attainment 
[103]. In Sweden, about 45% of the age groups born in the mid 1980‟s had started a 
university education at age 25. However, the probability to start university was strongly 
related to the parent‟s level of education; among those with parent‟s who only had 
primary/lower secondary (in Swedish: förgymnasial) education, 21% went on to 
university [103]. Among those who had a parent with a research education, the 
corresponding figure was 83%. Further, these differences were even higher for 
university educations that required high grades.  
An example from six municipalities  
Socio-economic status, whether it is measured as education, occupation or income, is 
related to behaviours (smoking, diet, physical activity) and to health both among 
children and adults [97]. As an illustration we can go back to the municipalities in 
Stockholm County that had the highest and lowest prevalence of maternal smoking 
during pregnancy in 2006. Where maternal smoking was highest (Norrtälje, 
Nynäshamn and Södertälje), the part of the population with the lowest group of 
educational attainment (primary/lower secondary school) ranged between 17-21% and 
the highest group of education (≥3 year‟s post-secondary education) ranged between 
14-18%. The corresponding percentages for the municipalities with lowest maternal 
smoking (Danderyd, Vaxholm and Lidingö) were 7-9% in the lowest educational group 
and 32-54% in the highest group [104]. The relative share of employment (% gainfully 
employed) was between 72-78% in Norrtälje, Nynäshamn and Södertälje vs. 82-86% in 
Danderyd, Vaxholm and Lidingö [104]. As expected, there were also differences in 
income between the municipalities [105]. Life expectancy was on average three years 
longer for a girl born 2007-2011 in Danderyd, Vaxholm or Lidingö compared to a girl 
born in Norrtälje, Nynäshamn or Södertälje (Figure 4) [106]. 
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2.8 TWINS  
In Sweden, twin pregnancies constitute 1.5-2.0% of all pregnancies [12]. Twins can be 
dizygotic (DZ) or monozygotic (MZ). Dizygotic or fraternal twins originates from two 
different fertilized eggs, they can have either the same or the opposite sex and are as 
similar as siblings in general. Monozygotic or identical twins originate from one single 
fertilized ovum and are hence genetic clones. Roughly, one third of the twins are like-
sexed DZ, one third is opposite-sexed DZ and one third is MZ. Dizygotic twin 
pregnancy is associated with higher maternal age, fertility treatment and inheritance 
[12]. The differences in twinning frequency between ethnic groups are due to 
differences in dizygotic twinning [12]. Monozygotic twin pregnancy is considered as a 
random event [12], although rare familial cases have been reported e.g. due to 
abnormalities in the zona pellucida [107].  
 
Twins are on average smaller at birth than singletons and are generally born after 
shorter gestations. Average gestational length in twin pregnancies is 36-37 weeks 
compared to 39-40 weeks in singleton pregnancies [12]. Mean birth weight is up to one 
kilo lower among twins than among singletons [12]. Discordance in birth weight in 
twin pairs can be due to unequal placenta sharing or peripheral/velamentous umbilical 
cord insertion [108,109]. Birth weight differences above 25% of the larger twin‟s birth 
weight have been suggested as a cut off for what should be regarded as clinically 
relevant [12]. While differences in birth weight within a twin pair is due to differences 
in nutritional supply, differences in birth weights between unrelated twins are likely to 
be due to the same factors determining birth weight in singletons.  
Twin studies 
The aim of twin studies is often to separate effects of environment and genes. In the 
classical twin study dizygotic and monozygotic twins are compared. Briefly, the idea is 
that all twins share intrauterine and childhood environment, while DZ twins also share 
on average 50% of their genes and MZ twins share 100% of their genes. Hence, MZ 
twins constitute a way to, at least theoretically, completely control for genetic factors. If 
the studied association is due to familial factors (genes and environment) the 
association is expected to be weakened or diminished within twins. A further decrease 
among MZ twins compared to DZ twins suggest importance of genetic factors [110].  
Chorionicity 
If monozygotic and dizygotic twins differ in other ways than genetic similarity, this 
threatens to complicate the interpretation of twin studies. One such suggested 
possibility is chorionicity [111]. Chorion is the outer membrane enclosing the foetus 
(the inner membrane is called amnion). All dizygotic twins are dichorionic, i.e. the twin 
siblings have separate chorion, amnion and placentas (although the placentas can be 
fused) [107]. Monozygotic twins that were separated day 0-3 after fertilization also 
become dichorionic (about 25-30%), while those separated after this time becomes 
monochorionic and share one single placenta [107]. Monozygotic twins that are 
separated late (after day 7) also become monoamniotic, i.e. both twins lie in the same 
amniotic sac. This occurs in about 1-2% of monozygotic twin pregnancies [107]. Twins 
separated after day 14 do not separate completely and become conjoined twins.    
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3 AIMS 
The overall aim of this thesis was to study how factors during prenatal and early life 
can influence health outcomes over the lifespan, taking familial confounding into 
account. 
The specific aims were: 
 
 To study if maternal smoking cessation from one pregnancy to another will 
influence the risk of stillbirth, in order to seek support for the hypothesis of a 
causal relationship. (Study I) 
 
 To study if maternal smoking during pregnancy influences blood pressure in 
adolescent offspring, and to investigate if a possible association could be 
explained by shared familial factors. (Study II) 
 
 To study if intergenerational social mobility (between parental and adult 
socio-economic status group) influences risk of hypertension and if a possible 
association is explained by shared familial factors. (Study III) 
 
 To study if the tendency to repeat birth weights across generations is 
explained by genetic or environmental factors. (Study IV) 
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4 MATERIALS AND METHODS 
4.1 SETTINGS 
The studies that this thesis is based upon are all set in Sweden and utilize information 
from population based registers. Sweden has a long history of population based 
statistics; the first national census was for example conducted in 1749 [112]. Since 
1947, all Swedish residents have a unique personal registration number that is given at 
birth or immigration. This is a ten digit number consisting of year, month, day of birth 
and four additional digits (YYMMDD-XXXX). The personal registration number 
enables register linkage at the individual level which provides great opportunities for 
epidemiological research [113]. 
4.2 DATA SOURCES 
The Medical Birth Register 
The Medical Birth Register started in 1973 and serves the purpose of surveillance of 
antenatal, obstetric and neonatal care. It covers 97-99% of all pregnancies resulting in a 
delivery in Sweden [114], and reporting to the register is required by law. Copies of 
medical records from prenatal, delivery and neonatal care are sent to the National 
Board of Health and Welfare (Socialstyrelsen) who keeps the register. The amount of 
collected information has changed and expanded several times. Smoking in early 
pregnancy has been registered since 1983. This information is obtained by midwifes at 
the women‟s first visit to antenatal care which, in 95% of pregnancies, takes place 
before the 15
th
 week of gestation [115]. The information is collected in a standardized 
way, using check boxes, where women are categorized as: non-smokers (i.e. non-daily 
smokers), moderate smokers (1-9 cigarettes per day) and heavy smokers (10 or more 
cigarettes per day). These categories have been validated by cotinine measurements and 
shown to have acceptable validity [116]. Since 1990, information about smoking three 
months prior to pregnancy has been collected; however the coverage was low during 
the first years. In 1999, smoking in pregnancy week 30-32 and information about use of 
oral moist snuff (“snus”) was added. In Studies I and II, only information about 
maternal smoking in early pregnancy is used as the other variables were introduced 
later and have insufficient coverage. Birth weights and birth lengths of the new-borns, 
which have been reported since the start of the register are measured directly after birth 
to at least the nearest 10 g and cm, respectively. Stillbirth has also been registered since 
1973. Up to July 2008, stillbirth was defined as foetal death after at least 28 completed 
weeks of gestation. Thereafter the definition was changed to foetal death after at least 
22 completed weeks of gestation, in accordance with international practise.    
The Conscript Register 
In 1901, Sweden introduced compulsory national service for all young men. During 
conscription, which most often took place at age 18, tests were performed to grade and 
place the young men for military service. Basic examinations included tests of IQ, 
hearing, vision and colour vision, measurements of height and weight, a general 
examination by a physician and an estimate of physical fitness. The young men who 
were considered physically and mentally suited for military service proceeded to 
additional tests, including electrocardiogram (ECG), pulse and blood pressure 
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measurements and maximal fitness tests (cycle and muscle capacity). The measurement 
of blood pressure was taken once in supine position, in the right arm, after five minutes 
of rest. Both manual and automatic cuffs were used, and in case of an uncertain reading 
an extra manual measurement was performed. Weight was measured in kg (in light 
indoor clothes) and height in cm (without shoes). In the beginning of the 1990s, the 
number of men drafted to complete military service decreased rapidly, however they 
still went through conscription. In 2007, a self-rating test of suitability for military 
service was introduced and calls for conscription were based on this rating. This 
resulted in a substantial decline in number of conscripts, which limited the possibilities 
for epidemiological research based on the Conscript Register from 2007. In 2010, the 
compulsory national service was abolished in peace time and conscription ceased. The 
data that has been collected over the years is still a rich source for research, but it is no 
longer renewed. The register is managed by The National Service Administration 
(Rekryteringsmyndigheten) former Swedish Defence Recruitment Agency 
(Pliktverket).     
The Swedish Twin Register 
The Swedish Twin Register started in the late 1950‟s with the primary purpose to study 
effects of smoking and alcohol on health. Over the years different birth cohorts of twins 
have been included. Information has been collected through questionnaires and 
interviews and additional information have been obtained through linkage to other 
registers. Today the Swedish Twin Register holds information about more than 170 000 
individual twins in 85 000 twin pairs [117]. The register is managed by Karolinska 
Institutet and constitutes a fantastic source for research aiming at separating effects of 
genetic and environmental influences. The second and the third birth cohort in the twin 
register were used in this thesis (Study III and IV). The second cohort comprised twins 
born 1926-1958. All like-sexed twins were in 1973 asked to respond to a postal 
questionnaire (Q73), with questions about health and lifestyle factors. In 1998-2002, all 
twins from this cohort alive and living in Sweden were contacted again and asked to 
participate in a telephone interview called SALT (Screening Across the Lifespan Twin 
Study) [118]. The purpose was to screen for common complex diseases. Questions 
involved symptoms, diagnoses and lifestyle factors. In 2005, the third cohort in the 
Twin Register, comprising twins born 1959-1985, was contacted and asked to answer a 
similar web-based questionnaire called STAGE (The Study of Twin Adults: Genes and 
Environment) [117]. Response rates were generally high: 83% responded to Q73, 74% 
responded to SALT and 66% responded to STAGE [117,118]. The twins‟ zygosity was 
determined from questions of childhood similarity. In Q73, twins were asked if they as 
children were as like as “two peas in a pod” (in Swedish “lika som bär”). In SALT and 
STAGE, the twins were also asked how often strangers had difficulties distinguishing 
them from their co-twin during childhood. In SALT, this method of zygosity 
determination was validated with DNA analysis in a subsample of 199 twins and 
proved correct in 99% of the cases [118]. Birth characteristics (birth weight, birth 
length, gestational age etc.) for the twins born 1926-1972 have been collected manually 
from original birth records, found in archives throughout Sweden. Birth characteristics 
for twins born 1973 or later have been retrieved from the Medical Birth Register. 
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The Multi-Generation Register 
The first version of the Swedish Multi-Generation Register was created in year 2000 
and a new version is created annually. It contains all people born 1932 or later who 
have been registered by the Swedish authorities at some time since 1961. These people 
are called index persons. The Multi-Generation Register then links all index persons to 
their biological and, if applicable, adoptive parents. At present there are about nine 
million index persons in the register. This provides a great opportunity for research as it 
enables family linkages.   
Education Register 
The Education Register is available from 1985 and is updated annually. Information 
about the population comes from the Register of the Total Population and information 
about education comes from universities, schools and education providers. For 
immigrants information about education is collected through questionnaires. 
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4.3 FAMILY BASED METHODS 
An association between an exposure and an outcome does not necessarily imply that 
the association is causal, that is, that the exposure causes the outcome. Other factors can 
influence the found association and one can only adjust for such factors if they are 
known and if they can be measured. As it is impossible to have knowledge about and 
measure all such factors, observational studies contain both unknown and unmeasured 
confounding to some degree. Related individuals, such as siblings and twins, may share 
many of these factors as they to different extent share genes and family environment. 
This is what family based methods take advantage of. They are often used to 
investigate if a found association is due to shared familial factors, i.e. shared 
environment and/or common genes. Full siblings share similar childhood environment 
and on average 50% of their segregating genes. They also share some, but not all 
maternal factors (the prenatal environment). Twins are a special kind of siblings, who 
share both intrauterine and childhood environment. Further, monozygotic (MZ) twins 
are genetic clones and share 100% of their genes, while dizygotic (DZ) twins are as 
similar as ordinary siblings and share on average 50% of their segregating genes. By 
stratifying an analysis on twins‟ zygosity it is possible to gain insights about the 
influence of genetic vs. environmental factors. If familial factors are important for a 
found association, it is expected that the association is weaker within family members 
(assuming no confounding from unshared environmental exposures or measurement 
error [119]). If the association is non-present within siblings or twins, the association 
could be due to familial confounding. If the association remains within DZ twins but 
not within MZ twins, this points towards an influence of genetic factors. Children of 
twins can also be informative as children of MZ twins are genetically half siblings and 
children of DZ twins are common cousins. In this thesis, siblings differentially exposed 
to maternal smoking during pregnancy were investigated in Studies I and II. In Studies 
III and IV twin data was used to assess familial confounding. These within twin/sibling 
pair analysis were all nested within cohort studies. The two following designs were 
used. 
Co-twin control design 
In the co-twin control design, twins discordant for the exposure are followed over time 
and the risk of the outcome is evaluated. In the similar co-twin case-control design, 
twins discordant for the outcome are used. The latter is equivalent to a case-control 
study with a 1:1 matching within twin pairs [110]. The twin with the outcome is the 
case and his or her healthy co-twin is the control, the matching refers to all shared 
familial factors. Only discordant (for exposure or outcome, respectively) pairs 
contribute with information in these analyses. In Study III, the co-twin case-control 
design was used with the hypertensive twin as case and the healthy co-twin as control. 
If the twin with higher socio-economic status in adulthood has lower odds of 
hypertension than his/her co-twin, this would indicate that the association between low 
social status and hypertension is not attributed to familial factors. 
 
In Study I, a “co-sibling control design” or “consecutive birth analysis” was used. This 
is very similar to the co-twin control design, but utilizes consecutive siblings instead of 
twins. Siblings (foetuses) differentially exposed to maternal smoking during pregnancy 
were followed and their stillbirth risk was estimated. If maternal smoking is causally 
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related to stillbirth, it is expected that the exposed foetus will have a higher risk 
compared to its non-exposed sibling. 
Between and within design 
In the “between and within” design, the regression coefficient of the exposure is 
decomposed into a between-cluster or cluster-level component and a within-cluster or 
individual-level component [120]. The between component is estimated by the 
twin/sibling pair mean. The within component is estimated by the individual deviance 
from the twin/sibling pair mean. In this thesis the between component is not reported 
since it was not the focus of the analyses. The within component can be thought of as 
an estimate of the exposure on the outcome that is independent of all factors shared by 
twin/sibling pairs. A simplistic explanation of the conceptual idea is that the more 
family members resemble each other the less the deviate from each other. In Study II, 
the within family effect estimates the expected change in offspring blood pressure by a 
one unit change in maternal smoking behaviour between pregnancies (that is, going 
from smoker to non-smoker or the other way around). In Study IV, the within twin pair 
component estimates the expected change in offspring size at birth by a one unit change 
in mother‟s size at birth (one unit is defined as 500 g or 1 cm). 
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Table 5. Overview of study design and study population in Study I-IV. 
 Study I Study II Study III Study IV 
Study design Cohort (with “co-
sibling control” 
analysis, not 
published in the 
article) 
 
Cohort with nested 
within sibling 
analysis 
Cohort with nested 
co-twin case-
control analysis 
Cohort with 
nested within twin 
analysis 
Data sources Medical Birth 
Register, 
Education 
Register, 
Immigration 
Register  
 
Medical Birth 
Register, 
Conscript 
Register, Multi-
Generation 
register 
Swedish Twin 
Register 
Swedish Twin 
Register, Medical 
Birth Register 
Study population All Swedish 
women who had 
their first and 
second births 
between 1983 and 
2001 
 
All young men 
born in Sweden 
1983-1988 who 
conscripted for 
military service in 
2001-2006 
All like-sexed 
twins born in 
Sweden between 
1926 and 1958 
All like-sexed 
female twins born 
in Sweden 1926-
1985 who had 
their first child 
between 1973 and 
2009 
Numbers (%)*  467 878 (89%) 87 223 (43%)  
9448 full brothers 
780 discordant 
brother pairs 
20 560 (55%) 
1
 
12 324 (33%) 
2
 
12 030 (32%) 
3
 
8685 (81%)  
1479 DZ pairs 
1526 MZ pairs 
 
Exposure Maternal smoking in early pregnancy Parental SES
1
 
Adult SES
2
 
Social mobility
3
 
 
Mother‟s birth 
weight and length 
Outcome Stillbirth  Blood pressure Hypertension Offspring‟s birth 
weight and length 
 
Confounders Mother‟s age, 
education, birth 
country, 
cohabitation with 
the infant‟s father, 
inter-pregnancy 
interval, previous 
stillbirth and year 
of second delivery 
Age, height, BMI, 
parent‟s education 
and cohabitation, 
mother‟s parity 
and blood pressure 
disease during 
pregnancy. 
Birth year, sex, 
birth weight, 
gestational age, 
mother‟s age at 
delivery, parity, 
adult height, BMI, 
alcohol 
consumption and 
smoking. 
 
Mother‟s 
education and 
gestational age, 
offspring‟s birth 
year and 
gestational age. 
*Numbers in the cohorts with full information about both the exposure and the outcome. In parenthesis, 
how large this fraction is compared to the whole study population (after exclusions not listed in this 
table).  
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4.4 STUDY DESIGN, POPULATION AND STATISTICAL METHODS 
Study I: Maternal smoking during pregnancy and stillbirth risk 
This is a population based cohort study where maternal smoking habits during two 
successive pregnancies are investigated in relation to stillbirth risk in the second 
pregnancy. Data mainly comes from the Medical Birth Register but linkage was also 
done to the Education and the Immigration Registers.  
 
The study population was defined as all women in Sweden who delivered their first and 
second consecutive single births between 1983 and 2001. In total, there were 526 691 
such women, of whom 467 878 (89 %) had information about first trimester maternal 
smoking in both pregnancies. The women were categorized as non-smokers in both 
pregnancies (reference group), smokers in first pregnancy/non-smokers in second 
pregnancy (quitters), non-smokers if first pregnancy/smokers in second pregnancy 
(starters) and smokers in both pregnancies. The outcome of interest was stillbirth in the 
second pregnancy (defined as foetal death after at least 28 completed weeks of 
gestation). Gestational age was determined by early second-trimester ultrasound 
screening when available, otherwise the last menstrual period was used. Routine 
ultrasound screening was introduced in Sweden in the 1980‟s. Since 1990 all pregnant 
women in Sweden have been offered this examination and 95% accept the procedure 
[13]. As potential confounders mother‟s country of birth, education, age, cohabiting 
with the infant‟s father, inter-pregnancy interval and previous stillbirth was considered. 
Year of second delivery was also included to capture a possible time effect. 
 
Logistic regression was used in the analyses. Crude and adjusted estimates are 
presented as odds ratios (OR) with 95% confidence intervals (CI). Adjustments were 
made for potential confounding factors as mentioned above. An additional conditional 
logistic regression analysis was performed after the study was published. This 
additional analysis utilizes information from differentially exposed siblings, by 
comparing the odds of stillbirth for the exposed sibling compared to the unexposed “co-
sibling” (equivalent to the co-twin control design). The outcome was then stillbirth in 
either pregnancy, while in the cohort analyses only risk of stillbirth in the second 
pregnancy was studied. This analysis was adjusted for mother‟s age, cohabitation with 
the infant‟s father and birth order of the children. The analyses were performed using 
SAS version 9.1 and 9.3. (SAS Institute Inc. Cary, NC, USA). 
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Study II: Maternal smoking during pregnancy and adolescent 
offspring blood pressure 
This is a population based cohort study with a nested within sibling analysis. Maternal 
smoking during pregnancy was studied in relation to late adolescent offspring blood 
pressure. Full brother pairs where one brother had been exposed to maternal smoking 
during pregnancy and the other had not were identified in the cohort. Data from the 
Conscript Register, the Medical Birth Register, the Multi-Generation Register and the 
Education Register (in 1990) was used.  
 
The study population consisted of all men born in Sweden between 1983 and 1988 who 
conscripted for mandatory military service between 2001 and 2006. Those who died or 
emigrated before age 18 (the age of conscription) were naturally excluded. To achieve 
higher homogeneity in the cohort, those with mothers‟ born outside the Nordic 
countries, those who had a congenital malformation or were multiples were excluded. 
After these exclusions, there were 259 515 men registered in the Medical Birth 
Register, of whom 201 701 went through the conscription procedure. Information about 
blood pressure was available for 92 730 of these young men. Full information about 
both maternal smoking during pregnancy and blood pressure was available for 87 223 
men. Within this cohort 9 448 full brothers were identified, and among them 780 
brother pairs were discordant for maternal smoking. Maternal smoking was categorized 
as non-smoker, moderate smoker (1-9 cigarettes per day) and heavy smoker (10 or 
more cigarettes per day) in the cohort analysis. In the within brother analysis only non-
smoker and smoker was used. The outcomes were systolic (SBP) and diastolic (DBP) 
blood pressure measured at conscription. We chose to look at blood pressure as a 
continuous variable, rather than using a cut of for prehypertension or hypertension. This 
was because one single measurement of blood pressure is not enough to give a 
diagnosis of hypertension and hypertension is not very common in young healthy 
teenagers. From the registers, we also obtained information on potential confounders.  
 
Generalized estimation equation (GEE) models were used to estimate regression 
coefficients with 95% confidence intervals for late adolescent SBP and DBP as a 
function of maternal smoking during pregnancy. The reason to use GEE instead of a 
plain linear regression model was the correlated structure of the data (siblings). 
Univariate and multivariate analyses are presented. Adjustments were made for 
conscript characteristics (age, height and BMI), parental characteristics (education and 
cohabitation during pregnancy, which can be seen as a way to adjust for the family‟s 
socio-economic status), and pregnancy characteristics (parity and maternal blood 
pressure disease during pregnancy). In the within brother analysis, the effect on blood 
pressure within brothers differentially exposed to maternal smoking in utero was 
estimated. These analyses were adjusted for age, height, BMI at conscription, parental 
cohabitation during pregnancy and mother‟s blood pressure disease during pregnancy. 
All analyses were performed using SAS version 9.2. (SAS Institute Inc. Cary, NC, 
USA).  
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Study III: Intergenerational social mobility and the risk of 
hypertension 
This is a cohort study with a nested co-twin case-control analysis. The influence of 
parental social status, own social status in adulthood and social mobility were studied in 
relation to risk of hypertension. In the co-twin case-control analysis, twins who were 
discordant for hypertension were compared in relation to their adult socio-economic 
status. Data from the Swedish Twin Register was used.   
 
The study population consisted of all like-sexed twins born in Sweden from 1926 to 
1958.  In total there were 37 392 such twins in the Swedish Twin Register. Among 
them, 88% had responded to both the questionnaire in 1973 (Q73) and the telephone 
interview between 1998 and 2002 (SALT) [118]. Among them 20 560 (97%) had 
information about socio-economic status (SES) in adulthood and hypertension, 12 324 
(58%) had information about both parental SES and hypertension, and 12 030 (57%) 
had information about both parental and adult SES as well as hypertension.  
 
The exposures in this study were parental SES, SES in adulthood and social mobility. 
The latter was defined as a combination of parental and adult SES. Parental SES was 
defined as the highest SES of either parent, based on their occupation. Information 
about parents‟ occupation originally came from birth and delivery records collected 
from archives all over Sweden. This information was hence recorded prospectively. 
Information about the twins SES in adulthood was defined by their own occupation as 
reported in the interview in 1998-2002. Those currently employed were asked about 
their occupation during the last 12 months, those unemployed were asked about their 
last occupation, and those retired were asked about their primary occupation in 
adulthood. Both parental and adult SES was classified in line with the guidelines of 
Statistics Sweden [121]. The groups were then further merged into three categories: 
low SES (unskilled and skilled blue-collar workers and low-level white-collar 
workers), high SES (intermediate and high level white collar workers) and self-
employed (entrepreneurs and farmers). The classification of occupations into SES 
groups relies to a large extent on education and type of union organization. Blue-collar 
workers and low-level white-collar workers often have the same amount of education 
[121]. Low level white collar workers have also been suggested to share other 
characteristics with blue collar workers rather than with higher levels of white collar 
workers [9]. This was hence the rational for our categorization of SES. Social mobility 
was defined as the change between parental SES and SES in adulthood, which is the 
intergenerational mobility between the parental and offspring generation. It was 
categorized as stable low, upward mobile, downward mobile and stable high SES. 
Because of the diversity in background among self-employed workers we were not able 
to determine whether their mobility was upward or downward. This group was 
therefore excluded from analysis of social mobility.  
 
Information about the outcome measure, i.e. hypertension, came from the interview in 
1998-2002. Hypertension was defined as answering „yes‟ to the questions: „Do you 
have or have you had high blood pressure?‟ and „Do you take any medication daily?‟ 
and then naming an antihypertensive drug. Hence, this is self-reported and treated 
hypertension. A subject was defined as non-hypertensive if answering „no‟ to both 
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these questions, or naming a drug not listed as an antihypertensive medication. Subjects 
not answering the two questions, answering yes to the question about having 
hypertension but not naming an antihypertensive drug or answering no to the question 
but naming an antihypertensive drug were defined as unclassifiable (n=2 934; 12.1% of 
the defined study population).  
 
Generalized estimating equations (GEE) were used to obtain OR with 95% CI‟s for the 
association between SES and hypertension in the cohort of twins. GEE was used to take 
the dependency in the data into account (twin data). Because hypertension risk is so 
strongly associated with age no crude analysis is presented, instead the first model was 
adjusted for birth year and sex. The second model was further adjusted for pregnancy 
and birth characteristics (birth weight, gestational age, mother‟s age at delivery and 
parity) and adult characteristics (height, BMI, smoking and alcohol consumption). To 
investigate whether shared familial factors confounded the associations, we conducted 
a co-twin case-control analyses using conditional logistic regression. All analyses were 
performed using SAS version 9.2. (SAS Institute Inc. Cary, NC, USA).  
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Study IV: Intergenerational influence on birth size – genes or 
environment? 
This is a cohort study with a nested within twin pair analysis. The intergenerational 
influence on birth weight and birth length was studied in female twins and their 
offspring. In the within twin pair analysis, we wanted to see if female twin sisters 
discordant for birth weight reproduced their differences in birth weight in their own 
offspring. Data came from the Medical Birth Register which was linked to the Swedish 
Twin Register and Education Register.  
 
The study population consisted of all like-sexed twins with known zygosity who were 
born in Sweden between 1926 and 1985. These twins should further have given birth to 
their first offspring between 1973 and 2009. Only first born offspring were selected as 
parity is known to influence offspring birth weight [122]. Further exclusions were made 
for stillborn, multiples and infants with congenital malformations. Within a like-sexed 
twin pair, there is a risk that birth data of one twin has been mixed up with the co-
twin‟s information. To minimize this potential misclassification, the study population 
was restricted to twins with known birth order. For twins born 1926-1958, birth order 
was considered certain if they had been given names at birth or agreed on birth order in 
the questionnaires (Q73, SALT). For twins born 1959-1972, an algorithm was used that 
combined information from the medical records (birth weight, name if this was given at 
birth and time of birth) and the STAGE questionnaire (birth weight and birth order). 
For twins born 1973-1985, a different algorithm adapted from Johansson and 
Rasmussen was used [123]. This algorithm was based on information on birth order, 
birth weight and who had been the heavier infant at birth, using information from both 
medical records and the STAGE questionnaire. After these restrictions, our cohort 
consisted of 9 418 twin mothers with first born offspring, of whom 8 685 had full 
information about mothers‟ and offspring‟s birth weight and birth length. Within this 
cohort, we had 3 005 complete female twin pairs, of whom 1 479 pairs were dizygotic 
and 1 526 were monozygotic. The exposure in this study was mother‟s birth weight in 
grams and birth length in cm. This information was obtained from original birth records 
for twins born 1926-1973 and from the Medical Birth Register for twins born 1973-
1985 (information in the Medical Birth Register also originates from birth records). The 
outcome was the first born offspring‟s birth weight and birth length, which was 
obtained from the Medical Birth Register.  
 
We used generalized estimation equations (GEE) to account for the correlated structure 
of the data, i.e. twin pairs and present regression coefficients with 95% confidence 
intervals for the influence of a 500 g or 1 cm increase in mother‟s birth weight/birth 
length on offspring birth weight/birth length, respectively. We present both crude and 
adjusted estimates. Adjustments were made for mother‟s education, mother‟s 
gestational age, offspring‟s birth year, and offspring‟s gestational age. To investigate 
whether the association between mother‟s and offspring‟s birth weight is independent 
of common genetic or shared environmental factors, we performed within twin pair 
analyses [120]. We stratified these analyses on mother‟s zygosity to gain some insights 
about the potential contribution of genetic factors. All analyses were performed using 
SAS version 9.3 (SAS Institute Inc. Cary, NC, USA).  
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4.5 ETHICAL CONSIDERATIONS 
Medical research requires the public‟s trust. Without trust in that researchers have good 
intentions and are competent and honest, nobody would offer their time or money to 
support scientific work, nor follow recommendations based on the findings. This trust 
must not be violated; therefore research ethics are extremely important. To consider a 
study for publication, medical journals demand that it has been approved by an ethics 
committee. Since 2004, this has also been regulated by law in Sweden (Lag om 
etikprövning 2003:460). All studies based on sensitive personal information, such as 
health information, must be approved by an ethics committee before start up. The ethics 
committees are composed by a chairman and members representing both scientific (10 
members) and public (5 members) interests. Fundamental is that the ethics committee 
only approve research that “can be conducted with respect for human dignity and if 
human rights and fundamental freedoms are constantly heeded” [124]. This has its 
history in the Second World War, where many torture-like and deadly experiments 
were carried out by physicians in concentration camps. At the end of the war, the 
physicians were held responsible during the Doctor‟s Trial. From this trial the 
Nuremberg code stems. It was the first written ethical code concerning medical 
research and has become the most influential [125]. While the Nuremberg code focus 
on research subject‟s human rights, another influential code, the Helsinki declaration, 
focus on the physician‟s/ investigator‟s obligations to the research subjects [125]. Good 
ethics goes hand in hand with good research [126]. The codes point out that research 
should be well designed and carried out by qualified persons. If not, it would be a waste 
of both resources and study participants time, or worse, lead to incorrect conclusions. 
There is also researcher ethics that applies to the individual researcher. This is about 
being honest, thorough and just to colleagues, to not cheat or modify the results; again, 
it is a matter of trustworthiness [126].  
 
The studies in this thesis are register based and includes many thousand participants. It 
would not be practical or economically defensible to get an informed consent from 
every single registered person. Instead, the ethics committee judge if the potential 
benefit from the studies outweighs the potential harm. The used register data was 
anonymous, i.e., no names or personal numbers are given out to researchers from the 
responsible authorities (National Board of Health and Welfare and Statistics Sweden). I 
believe that possible harm from violation of integrity by these studies is minimal. It is 
further important to think about how findings are presented and discussed. Increased 
stigmatization of vulnerable groups or victim blaming should be avoided, at the same 
time as the results must be presented truthfully. Sensitive topics in this thesis might be 
characteristics of women who smoke during pregnancy and differences in behavioural 
factors between socio-economic groups. In a respectful way, I believe most topics can 
be addressed. 
 
All studies in this thesis were approved by the research ethics committee at Karolinska 
Institutet (Study I-IV dnr numbers 4863/2005; 2007-546-31; 00-410; 2006-874-32; 
2006-1297-32; 2010-1585-32).  
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5 RESULTS 
 
Study I: Maternal smoking during pregnancy and stillbirth risk 
In this study population, 21.4 % of the pregnant women smoked in their first pregnancy 
(14.3% were moderate smokers and 7.1 % were heavy smokers), and 17.8 % smoked in 
their second pregnancy (11.5 % were moderate smokers and 6.3 % were heavy 
smokers). The majority of women who smoked during their first pregnancy also 
smoked during their second pregnancy (64.6% of moderate smokers and 81.4% of 
heavy smokers). Stillbirth rate was 4.5/1000 in first pregnancy (N=2 363) and 2.7/1000 
in the second pregnancy (N=1 420). Maternal smoking of ten or more cigarettes per day 
was significantly associated with increased odds of stillbirth.  
 
Odds of stillbirth in the second pregnancy were also associated with several maternal 
characteristics. A previous stillbirth in the first pregnancy was associated with 
substantially increased odds of a second stillbirth (adjusted OR 2.42 95% CI 1.32-4.41). 
The risk of stillbirth was further increased among women with high maternal age (≥35 
years), a non-Nordic country of birth, and a long inter-pregnancy interval (≥3 years). 
Among teenage mothers (≤19 years) the rate of stillbirth was relatively high (4.7 per 
1000); however after adjustment for smoking and other variables, low maternal age was 
no longer significantly associated with stillbirth risk. High maternal education was 
associated with a decreased risk of stillbirth. 
 
For women who were former (moderate or heavy) smokers, odds of stillbirth in the 
second pregnancy were similar to the odds among women who were non-smokers in 
both pregnancies (Table 6). Compared with non-smokers in both pregnancies, women 
who were smokers in both pregnancies generally experienced increased odds of 
stillbirth in the second pregnancy. No effects on odds of stillbirth were seen for women 
who stated that they were non-smokers during the first pregnancy but smokers during 
the second pregnancy. 
Table 6. Cohort analysis of stillbirth rates in second pregnancy in relation to 
smoking habits in first and second pregnancy. 
 
Maternal smoking   
1
st
 pregnancy / 2
nd
 pregnancy 
Stillbirth in 2
nd
 pregnancy 
 Rate / Odds ratio (95% CI) 
No 1000 Crude Adjusted* 
 
Non-smoker/Non-smoker† 
 
863 
 
2.4 
 
1.00 
 
1.00 
Non-smoker/Smoker 26 2.2 0.89 (0.60-1.32) 0.84 (0.56-1.26) 
Smoker/Non-smoker 79 2.7 1.11 (0.88-1.40) 1.01 (0.79-1.30) 
Smoker/Smoker 236 3.4 1.41 (1.22-1.63) 1.35 (1.15-1.58) 
*Adjusted for the effects of maternal age, education, cohabiting with infant‟s father, 
mother‟s country of birth, inter-pregnancy interval, stillbirth in the first pregnancy 
and year of (second) delivery. 
†Reference group.  
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In the additional sibling analysis (not available in Study 1), increased odds of stillbirth 
was seen for the sibling who had been exposed to maternal smoking during pregnancy 
compared to the unexposed sibling (Table 7). The point estimates were even higher in 
the sibling analysis compared to those seen in the cohort, for maternal smoking of ten 
or more cigarettes per day the risk of stillbirth was more than doubled. 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7. “Co-sibling control analysis” with children differentially exposed to 
maternal smoking in utero. The odds of stillbirth for the exposed sibling 
compared to the unexposed sibling.  
 Crude Adjusted* 
Maternal smoking during pregnancy OR (95 % CI) OR (95 % CI) 
 
Moderate smoker vs. non-smoker  
 
1.43 (1.14-1.80) 
 
1.21 (0.93-1.58) 
Heavy smoker vs. non-smoker 2.57 (1.90-3.48) 2.17 (1.53-3.07) 
 
*Adjusted for maternal age, cohabitation with the child‟s father and birth order. 
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Study II: Maternal smoking during pregnancy and adolescent 
offspring blood pressure 
The mean SBP in the cohort was 130.7 mm Hg, and the mean DBP was 69.3 mm Hg. 
Mean blood pressure was positively correlated with maternal smoking during 
pregnancy, conscript‟s height and BMI. Birth weight for gestational age and gestational 
age showed a negative association with mean blood pressure. The prevalence of 
prenatal exposure to maternal smoking in the cohort was 26.2% (16.8% had mothers 
who were moderate smokers and 9.3% had mothers who were heavy smokers).  
 
There was a small positive association between maternal smoking during pregnancy 
and late adolescent offspring SBP and DBP (Table 8). For SBP, the estimate was 
statistically significant among sons whose mothers had been smoking 10 or more 
cigarettes per day [β: 0.53 (95% CI: 0.26 to 0.80)] and non-significant for sons whose 
mothers had smoked 1-9 cigarettes per day [0.12 (-0.09 to 0.33)]. Point estimates for 
the increase in DBP were higher and statistically significant for sons of both moderate 
and heavy smokers. The strongest attenuations in these associations were seen after 
adjustment for BMI and parental education.  
 
 
 
 
 
 
 
Table 8. Regression coefficients (β with 95% CI) for the association of maternal 
smoking during pregnancy and offspring blood pressure in late adolescent in a 
cohort of Swedish males born 1983-1988. 
 
 Crude Adjusted * 
Systolic blood pressure   
Non-smoker† 0 0 
Daily smoker 0.35 (0.17-0.52) 0.26 (0.09-0.44) 
   1-9 cig/day 0.18 (-0.02-0.39) 0.12 (-0.09-0.33) 
   ≥10 cig/day 0.64 (0.38-0.90) 0.53 (0.26-0.80) 
 
Diastolic blood pressure   
Non-smoker† 0 0 
Daily smoker 0.57 (0.44-0.70) 0.45 (0.31-0.59) 
   1-9 cig/day 0.43 (0.27-0.58) 0.33 (0.17-0.49) 
   ≥10 cig/day 0.82 (0.62-1.02) 0.67 (0.47-0.88) 
  
 
Total number 87 223 85 438 
* Adjusted for age, height, BMI, parental education and cohabitation status, parity and 
maternal blood pressure disease during pregnancy. 
†Reference group 
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In the within brother analysis, the regression coefficients represent the expected change 
in offspring blood pressure (mm Hg) for a one unit change in maternal smoking habits 
(from smoking to non-smoking or the other way around). Within brother pairs, the 
expected change was 0.69 mm Hg (95% CI: -0.67 to 2.04) for SBP and 1.14 mm Hg 
(95% CI: 0.10 to2.17) for DBP if the mother had smoked during pregnancy compared 
with if she had not. Adjustments for potential confounders resulted in a loss of 
significance for the DBP estimate, but the point estimates were only slightly changed 
(Table 9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 9. Crude and adjusted estimates (β with 95% CI) of the expected change 
in blood pressure (mm Hg) in male full siblings discordant for maternal smoking 
during pregnancy following a change in smoking status between pregnancies. 
 
 Crude Adjusted* 
Systolic blood pressure 0.69 (-0.67-2.04) 0.81 (-0.56-2.19) 
Diastolic blood pressure 1.14 (0.10-2.17) 0.85 (-0.19-1.90) 
Total number of discordant brothers 780 758 
*Adjusted for age at conscription, height, BMI, parental cohabitation status at time of 
pregnancy, parity and maternal blood pressure disease during pregnancy. 
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Study III: Intergenerational social mobility and the risk of 
hypertension 
The overall prevalence of hypertension in the cohort was 15.8%. The prevalence 
increased with increasing BMI and alcohol consumption and was inversely associated 
with birth year, socioeconomic status (both parental and adult), birth weight and height. 
Compared to those who had parents with high SES, those whose parents had low SES 
had 55% increased odds of hypertension and those who had self-employed parents had 
23% increased odds of hypertension (borderline significant). These estimates were 
essentially unchanged after adjustments for both birth and adult characteristics, while 
further adjustment for adult SES slightly attenuated the odds. There was no interaction 
between parental SES and sex (p=0.95). However, between adult SES and sex (p=0.03) 
there was a significant interaction and the analyses were therefore stratified by sex. 
Among men no association between adult SES and hypertension was seen. Among 
women with low adult SES the odds of hypertension was increased by 31% compared 
to women with high adult SES. In the social mobility analysis, information about 
parental SES and adult SES was combined. Compared to those with high SES in both 
generations, those with low SES in both generations, the upward mobile group, and the 
downward mobile group (not statistically significant for the last group) had increased 
odds of hypertension (Table 10). These results were slightly attenuated after 
adjustments for birth and adult characteristics. In the co-twin case-control analysis, we 
could only include those with low parental SES as the variation within twin pairs was 
too small to yield meaningful estimates in the group with high parental SES. Although 
not statistically significant, the point estimates indicated decreased odds of 
hypertension for the upward mobile twin compared to the stable low SES co-twin. 
Table 10. Adjusted ORs (95% CI) for the intergenerational social mobility 
among Swedish like-sexed twins born from 1926 to 1958 and risk of 
hypertension. 
 Study 
population Hypertensive Odds ratios (95% CI) 
Social mobility 
over two 
generations N % Model 1* Model 2** 
 
Stable lower SES  4995 15.4 1.72 (1.36-2.17) 1.67 (1.29-2.17) 
Upward mobile 2676 12.5 1.46 (1.14-1.87) 1.39 (1.05-1.83) 
Downward mobile 577 10.8 1.26 (0.89-1.77) 1.23 (0.84-1.79) 
Stable higher 
SES† 1191 8.0 1.00 1.00 
Self employed 2591 11.5   
Missing  9184 19.6   
Total 
 
21214 15.8 12030 9316 
*Model 1: Adjusted for birth year and sex. 
**Model 2: Adjusted for birth year, sex, birth characteristics; birth weight, gestational 
age, mother‟s age at delivery and parity, and adult characteristics height, BMI, 
smoking and alcohol consumption. 
† Reference group 
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Study IV: Intergenerational influence on birth size – genes or 
environment? 
In this cohort, the mean difference in birth weight within dizygotic twin pairs was 349 g 
(range 10-1990 g) and within monozygotic twin pairs the mean difference was 310 g 
(range 10-1610 g). Offspring‟s birth weight and birth length generally increased with 
mother‟s birth weight, gestational age, birth weight for gestational age, birth length, 
birth year and education. No associations were seen between mother‟s zygosity or age 
at delivery and offspring‟s size at birth. Maternal smoking during pregnancy was 
inversely associated with offspring birth weight and birth length.  
 
In the full cohort of twins (both dizygotic and monozygotic), an increase of 500 g in 
mother‟s birth weight was associated with an increase in offspring birth weight of 101 g 
(95% CI: 89 to 113) and an increase in offspring birth length with 0.34 cm (0.29 to 
0.40) in the adjusted analyses. An increase in mother‟s birth length of 1cm was 
associated with an increase in offspring birth weight with 32 g (28 to 37) and an 
increase in offspring birth length with 0.15 cm (0.13 to 0.17). When stratified by 
zygosity, monozygotic twins had lower point estimates than dizygotic twins.  
 
Within dizygotic twin pairs, a one unit increase (500 g or 1 cm) in maternal birth 
weight/birth length difference from the twin pair mean was associated with statistically 
significant increases in offspring‟s birth weight and birth length (Table 11). Estimates 
were generally slightly lower than those seen in the cohort analyses of dizygotic twins. 
Within monozygotic twin pairs, neither a change in mother‟s birth weight, nor a change 
in mother‟s birth length deviance from the twin pair mean influenced birth weight or 
birth length in offspring.  
 
 
Table 11. Within twin pair analysis estimating the expected change in offspring 
birth weight according to a one unit change (500 g) of twin mother’s deviance 
from the twin pair mean size at birth, among 1479 dizygotic and 1526 
monozygotic twin pairs. 
 Offspring birth weight (g) 
Mother 
Crude  
β (95% CI) 
Adjusted* 
β (95% CI) 
 
Dizygotic twins 
   500 g increase 
 
 
74 (35 to 113) 
 
 
70 (35 to 106) 
   1 cm increase 26 (10 to 42) 26 (12 to 40) 
Monozygotic twins 
   500 g increase 
 
-12 (-49 to 26) 
 
8 (-25 to 41) 
   1 cm increase -4 (-19 to 10) 3 (-11 to 16) 
*Adjusted for offspring gestational age and year of birth and mother‟s education. 
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6 DISCUSSION 
6.1 METHODOLOGICAL CONSIDERATIONS 
Study design  
Before discussing the findings from the four studies, some general methodological 
considerations will be addressed. All four studies in the thesis are cohort studies with a 
nested within twin/sibling comparison. The co-twin case-control analysis (in Study III) 
has large similarities with a case-control study. 
Cohort study 
The word cohort comes from the Latin cohors, which in the Roman army constituted a 
group of soldiers, more exactly one tenth of a legion. In epidemiology, a cohort has 
been defined as “any designated group of persons who are followed or traced over a 
period of time” [127]. In a cohort study, exposed and unexposed individuals are 
followed over a period of time. Then the exposed group is compared to the unexposed 
group in terms of occurrence of the outcome. The idea is that, if the exposure does not 
have an effect on the outcome, there should be no differences in occurrence of the 
outcome between the exposed and the unexposed group. In prospective cohort studies, 
the exposure is assessed at the start, and new exposure information may be collected 
during follow-up. At the end of follow-up, the cohort is evaluated with regards to the 
outcome. Experiments, such as clinical trials, are prospective cohort studies where the 
exposure has been randomly assigned within the cohort. In retrospective cohort studies 
the follow up time has already past when the study is initiated. This is the case when 
historical data is used. If the information about exposure was collected before start of 
the follow up time, the data collection is still prospective, although the study is 
retrospective. The studies in this thesis are all retrospective, but with prospectively 
collected data.   
 
Cohort studies have several advantages, especially when the cohort is large and 
population based and data are prospectively collected. Prevalence, incidence and 
relative risks can be estimated; rare exposures can be studied; time between exposure 
and outcome can be assessed; and multiple outcomes can be studied. For many research 
questions, where an experimental design is not possible, a cohort study may be the best 
option. However, drawbacks for prospective cohort studies are that they often are 
expensive and in case of a long follow up time, it can take decades until results can be 
evaluated. Retrospective cohorts do not have these limitations to the same extent. 
Cohort studies can further be hampered by a large loss to follow up. Register based 
cohort studies are limited to the information on exposures and confounders that the 
registers contain. In this thesis this problem has partly been dealt with through register 
linkage.  
Case-control study 
In the case-control study, the approach is somewhat reversed compared to the cohort 
study. Participants who have the outcome (cases), are compared to subjects who are 
free of the outcome (controls) with respect to exposure information before disease 
development. It is essential that the controls should come from the population that 
generated the cases. Case-control studies are suitable when studying rare diseases, 
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diseases with long latency periods and multiple exposures. Case-control studies can be 
quicker to perform and cheaper than cohort studies. However, prevalence, incidence or 
multiple outcomes cannot be measured; the selection of controls can be difficult and 
introduce bias; if the exposure is common it might be difficult to find a difference 
between cases and controls; further, recall bias and reverse causation might be a 
problem.  
 
A case-control study is nested when the cases and the controls are taken from the 
population in a cohort study. In this thesis, nested within twin/sibling comparisons were 
used in all studies (not published in the article for Study I). The strength of these 
analyses is the possibility to adjust for unmeasured familial confounding.  
Internal validity 
Epidemiological studies are based on measurements [128]. They can, for example 
measure how common a disease is, if an exposure is a risk factor for a disease or which 
treatment that is the most effective for a disease. How reliable the measurement is 
depends on the validity and the precision. Validity is the absence of systematic error, 
and precision is the absence of random error. There are different types of systematic 
errors, so called biases. Random error is caused by chance. While random error can be 
dealt with through increasing the study population, systematic errors should be taken 
into consideration, both at the design and the data analysis stages.  
Selection bias 
Selection bias can occur in the process of selecting study participants, or through 
factors that influence study participation. There can be selection bias if the association 
between exposure and outcome is different between those who are selected/participate 
and those who theoretically would be able to participate, including those who were 
excluded/chose not to participate. Selection bias can be caused by, for example, 
differential loss to follow up, self-referral (self-selection bias) and diagnostic bias 
[129]. In Study II we only had blood pressure measurements for those who were 
considered suitable for military service (43% of the conscripts). Hence, this is a 
selection of men who were likely to be healthier than those not included in the study. 
Further, participants had been exposed to maternal smoking less often than non-
participants (29.2% vs. 26.2%); their parents had higher education and were more often 
cohabiting during pregnancy. However, this selection has probably resulted in a more 
homogenous population with higher internal validity and less confounding from socio-
economic factors. In Study III, there was a large part (42%) of the final study 
population who lacked information about parental socio-economic status (SES). This 
group also had higher prevalence of hypertension (19.5% vs. 15.8%) than the part of 
the cohort with information about parental SES. This difference was however entirely 
explained by differences in age between the groups; those who lacked information 
about parental SES were older and had somewhat lower adult SES than the part of the 
cohort with full information. This selection should rather have led to an 
underestimation of the association between parental SES and hypertension. In Study 
IV, only voluntary participants could be included as the zygosity determination depends 
on response to questionnaires. However, the response rates were rather high (Q73: 83% 
SALT: 73% STAGE: 66%) and probably not related to the exposure or outcome (birth 
weights).  
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Information bias 
Information bias, or misclassification, occurs when information about exposure or 
outcome for the study participants is incorrect. This can for example happen when 
study participants do not remember their exposure or outcome correctly (recall bias) or 
when study participants underreport or deny an exposure or outcome. Misclassification 
can be differential, i.e. related to other variables, or non-differential, i.e. unrelated to 
other variables [129]. Differential misclassification can either overestimate or 
underestimate an effect, while non-differential misclassification usually causes a 
dilution of the effect. Misclassification of confounding factors hampers the ability to 
control for the confounder in the analysis [129]. In Study I and II, the information about 
maternal smoking was self-reported by the women in early pregnancy. Self-reported 
smoking during pregnancy has been shown to have an acceptable validity [116,130]. 
However, it is known that some women underreport the number of cigarettes they 
smoke or completely deny the habit [116,131,132]. This might be an increasing 
problem for later years as smoking has become less and less socially acceptable. 
Further, 20-40% of women who report that they smoke in early pregnancy quit 
smoking later in pregnancy [5]. Therefore, it is probable that there is misclassification 
of exposure in Studies I and II, especially in the groups who reported a change in 
smoking habits between pregnancies. Assuming non-differential misclassification, it 
can have led to an underestimation of the associations between maternal smoking 
during pregnancy and stillbirth, and maternal smoking during pregnancy and offspring 
blood pressure, respectively. In Studies III and IV twin data was used. For like-sexed 
twins there is a risk that their birth characteristics have been mixed, so that the 
characteristics of twin A has been assigned to co-twin B, causing misclassification 
[123]. In Study III, this would be misclassification of a confounder (birth weight and 
gestational age) and in Study IV this would be misclassification of exposure. To 
minimize this misclassification the cohorts were restricted to twins with known birth 
order, using different algorithms. In Study IV, these algorithms partly built on self-
reported birth weight, which is open to some recall bias. In Study III, the prevalence of 
hypertension is probably underestimated, due to misclassification of the outcome. In 
the cohort, 16% were classified as hypertensive (aged 40-76). In Swedish samples, a 
prevalence of hypertension of 26-27% has previously been reported [89,133]. Self-
reported hypertension has been shown to have a high specificity (80-95%) but low 
sensitivity (43-82%) [134]. Assuming non-differential misclassification, this should 
have led to an underestimation of the association between socio-economic status and 
hypertension. Further, if the diagnosis and treatment of hypertension are socially 
patterned, those with low social status would probably be less likely to report 
hypertension than those with high social status; again, this would have led to an 
underestimation of the association between social status and hypertension.  
Confounding 
Confounding is a mixing of effects that distorts the association between exposure and 
outcome. Through a confounding factor (a confounder), an association between the 
exposure and the outcome can be underestimated, overestimated, created or even 
reversed. For a factor to be a confounder it has to: [135]  
1. Covariate with the exposure.  
2. Be a cause (or marker of a cause) of the outcome. 
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3. Not be in the causal pathway between the exposure and the outcome (i.e. a 
confounder should not be an effect of the exposure).  
 
Confounding occurs when the exposed and the unexposed groups differ in terms of 
such a third factor. It is possible to assess confounding at the design stage of a study 
through, for example, randomization or restriction. Through randomization all 
confounding factors, including the unknown, are randomly assigned between the 
exposed and the unexposed groups. If differences between the groups remain after 
randomization they are due to chance, hence, confounding is a random error in 
experimental studies. Through restriction, study participants who have the same, or 
nearly the same value on the confounder are selected into the study. This method can be 
used in all study designs. At the analysis stage confounding can be assessed through 
stratification or through adjustment in regression models, this requires that data on the 
confounders have been collected. In the stratified analyses different estimates are 
presented for different levels of the confounder. Compared to the multivariate 
regression analysis, it is easier to get an overview of what has happened to the data in 
the stratified analysis. In the multivariate analysis, on the other hand, it is possible to 
adjust for several confounders at the same time.  
 
Restriction was used in Studies II and IV. In Study II, the study population was 
restricted to men without congenital malformations, who had been singletons and 
whose mothers had been born in a Nordic country. As blood pressure data was only 
available for those who had been considered suitable for military service, the study 
population was in practice also restricted on the basis of that. In Study IV, the study 
population was restricted to include only the twin‟s first born offspring, this was done 
in order to avoid effects from parity.   
  
In all studies in this thesis confounding was assessed through adjustment in regression 
models. In Study I, information about maternal BMI, alcohol consumption, passive 
smoking and illicit drug use was lacking and could not be controlled for. In Study II, 
information about postnatal smoking was lacking. A large part of the parents who 
smoke during pregnancy also smoke after the baby has been born. It is, in Study II, not 
possible to separate effects of antenatal and postnatal smoking. In Study III, 
information about the confounders was obtained long before the outcome was assessed 
and they can therefore have changed over time. This can have led to an insufficient 
adjustment for confounders. However, we prioritized to use data collected before the 
occurrence of the outcome in order to avoid reverse causality. Further, considering the 
association between socio-economic status and hypertension, all covariates could also 
be thought of as mediators. Adjusting for them then becomes an attempt to investigate 
how much of the association between socio-economic status and hypertension that can 
be attributed to the specific covariates. All these adjustments require that the 
confounders are both known and measured. The idea of the twin/sibling pair 
comparisons is to further adjust for familial confounding, i.e. adjustment for 
environmental and genetic factors that might not be measured or even known.    
Effect modification/interaction 
A biological interaction is when the effect of one factor is dependent on the presence of 
another factor, this kind of interaction either exist or do not exist. An example of a 
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biological interaction is the metabolic disease phenylketonuria (PKU) [136]. To 
develop the disease (manifested as mental retardation), both the genetic mutation and 
exposure to the amino acid phenylalanine in the diet is required. Through diet 
restrictions the disease development can be prevented. A statistical interaction, or effect 
modification, occurs when the effect changes over values of a third variable, for 
example, when an exposure has different effects in young and old people or in men and 
women. Effect modification can be present on one scale but not another, e.g. there can 
be a statistical interaction on the risk ratio scale but not on the risk difference scale. 
Effect modification should be looked for if there is a biological or social hypothesis 
behind it. If detected, stratified analyses should be presented. In Study III there was a 
significant interaction between sex and adult socio-economic status, the analyses where 
therefore stratified by sex. Low adult socio-economic status was associated with 
hypertension in women, but not in men.   
Random error 
Rothman & Greenland describes random variation as the part of our experience that we 
cannot predict [129]. Often this is attributed to chance. Estimates from small study 
samples are more sensitive to the influence of random error, i.e. they often have lower 
precision. The primary way to increase precision/reduce random error in a study is 
therefore to increase the study size [129]. The confidence interval around a point 
estimate gives information about the amount of random error in the analysis. The 
interpretation of 95% confidence intervals is that; if the study could be repeated an 
unlimited number of times, the confidence interval would include the true value with a 
frequency of at least 95% [129]. This assumes that there is no systematic error in the 
study and that the statistical model used fits the data. As this most often is not 
completely true, the confidence intervals can rather be seen as a guide to the uncertainty 
in an epidemiologic result [129]. The width of the confidence interval reflects the 
precision of the estimate. Further, the width is influenced by the arbitrarily chosen 
significance level; the most common choice is 95%. As the studies in this thesis are all 
based on large cohorts, the precision should in general be good. However, some 
investigated groups within the cohorts can still be small and therefore have a larger 
statistical uncertainty; for example, the group of women who were non-smokers in their 
first pregnancy and smokers in the second pregnancy (starters) in Study I, and the 
group with downward social mobility in Study III. Furthermore, in Study II relatively 
few brother pairs were discordant for exposure to maternal smoking during pregnancy, 
and in Study III very few twin pairs were discordant for adult socio-economic status, 
which hampered the co-twin case-control analysis.  
External validity 
While internal validity is about how reliable the results are within the studied 
population, external validity refers to the generalizability of the results to other non-
studied populations or if the findings could be expressed as a scientific theory or 
hypothesis more or less separated from time and place [129]. This is often a matter of 
judgement and discussion. If the internal validity of a study is poor, external validity 
has no meaning. In Study II, only men were included and it is therefore not known 
whether the results would have been the same for women. Hence, these findings are not 
generalizable to women.  
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External validity of twin studies 
Twin studies have been pointed out as a way to investigate causal pathways underlying 
the association between birth size and adult disease, especially through between and 
within twin pair analyses [137]. McGue et al. even argues that discordant monozygotic 
twin pairs provide an analog to the counterfactual design [138]. However, the 
generalizability of findings among twins to the general population (which mostly 
consists of singletons) has been questioned [1,139,140]. Twins are in general smaller at 
birth and born after shorter gestations than singletons. In accordance with the DOHaD 
hypothesis, twins were therefore hypothesized to have increased risk of cardiovascular 
disease later in life. However, no such differences between twins and singletons have 
been found [141-143]. Furthermore, no difference in size at birth has been reported for 
offspring of twins compared to offspring of singletons [144]. It has therefore been 
argued that foetal growth in twins is biologically different from that in singletons and 
perhaps of limited use in investigating later health outcomes [1]. However, the 
association between low birth weight and later health among twins have shown similar 
results to those seen among singletons [54,140,145]. Further, in Study IV, we have seen 
that there is an intergenerational association in size at birth also among twin mothers 
and their children. Morley has argued that the general constraint in twins might not be 
associated with later health outcomes, while differences in foetal growth among twins 
might be [146]. That is, the association between birth weight and later health might 
differ quantitatively but not qualitatively, at least not for later blood pressure [147]. 
However, factors such as placentation and factors related to assisted reproductive 
technologies need to be considered [147].  
 
Other aspects of twin studies 
As all differences between monozygotic and dizygotic twins are interpreted as a genetic 
effect, twin studies usually overestimate the importance of genes. However, potential 
influences from gene-environment interactions, epigenetic differences and 
environmental factors that are more correlated within monozygotic twins cannot be 
ruled out [110].  
 
Studies III and IV were both based on twin data. In Study III, the twins were mainly 
analysed as a cohort since the co-twin case-control analysis was hampered by low 
precision and could not be stratified by zygosity. The described concerns about twin 
data is therefore of less importance in Study III and twins are probably representative 
for the whole population with regards to socio-economic status and social mobility. In 
Study IV, where intergenerational birth size was investigated, these concerns are of 
greater importance. We did not have information about chorionicity (which leads to a 
shared or separate placenta) and could hence not investigate if this could explain 
differences between monozygotic and dizygotic twins. Twin-to-twin transfusion 
syndrome (TTTS) could also be a cause of differences in birth weight between 
monozygotic and dizygotic twins, and above all within monozygotic monochorionic 
twin siblings. However, due to the poor prognosis of untreated TTTS [148], it is 
unlikely to have had an impact on our results.  
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6.2 FINDINGS AND IMPLICATIONS 
Maternal smoking during pregnancy and the risk of stillbirth  
Study I, shows that women who quit smoking between two consecutive pregnancies 
have the same risk of stillbirth in the second pregnancy as women who never smoked 
when pregnant. Women, who were smokers in one pregnancy and non-smokers in one 
pregnancy, had an increased risk of giving birth to a stillborn infant in the pregnancy 
where they smoked, compared to the pregnancy when they did not. There was also a 
dose-response relationship where risks increased with amount smoked. These results 
support that maternal smoking during pregnancy is causally related to stillbirth.  
 
However, no increased risk was seen among women who stated that they were non-
smokers in their first pregnancy and smokers in their second pregnancy (starters). This 
somewhat complicates the interpretation, but could be due to other causes touched upon 
previously, namely: misclassification, confounding and random error. First, smoking 
was only measured in early pregnancy and 20-40% quit smoking later during 
pregnancy [5]. Successful smoking cessation is related to degree of addiction and 
women who managed to sustain from smoking in the beginning of their first pregnancy 
are probably less addicted and more likely to quit later in pregnancy (which causes 
misclassification of exposure). Second, women who take up smoking between their 
pregnancies may differ from persistent smokers with respect to other factors 
influencing stillbirth risk such as BMI, weight change between pregnancies and 
obstetric history (i.e. confounding) [78,149,150]. Third, this group is smaller than the 
others and stillbirth is relatively uncommon, so even though the study population is 
large, this could be a chance finding (random error). Further, A.L.V. Johansson has 
shown that women who did not smoke in the first pregnancy but were heavy smokers 
(>10 cigarettes per day) in the second pregnancy had an increased risk of stillbirth in 
the second pregnancy (unpublished data). This was done by survival analysis using data 
from the Medical Birth Register.  
 
Previous studies have consistently reported an association between maternal smoking 
during pregnancy and stillbirth risk [5,80]. This seems to be true especially for preterm 
stillbirth [151]. Reported odds ratios range between 1.2 and 1.8 [5] and a dose-response 
relationship is usually obtained. Wisborg et al have shown that women who quit 
smoking in the first trimester have the same risk of stillbirth as women who never 
smoked during pregnancy [152]. However, Dodds et al showed that women who 
stopped smoking by the 16
th
 week of gestation still had an increased risk of stillbirth, 
similar to persistent smokers [153]. Further, the increased risk of stillbirth in women 
who smoke during pregnancy has been explained through increased risks of foetal 
growth restriction and placental complications [151]. Although smoking during 
pregnancy has decreased substantially since the 1980s, stillbirth rates have not. This 
might be explained by the concordant increase in maternal BMI and age, which also are 
important risk factors for stillbirth [58,154,155].  
To conclude, there is good evidence for a causal association between maternal smoking 
during pregnancy and stillbirth. Although smoking among pregnant women has 
decreased in Sweden, there are still groups where the prevalence is high. Smoking 
during pregnancy continues to be an important and preventable risk factor for stillbirth. 
   45 
Maternal smoking during pregnancy and offspring blood 
pressure  
Study II suggests that maternal smoking during pregnancy may increase offspring 
blood pressure in late adolescence. In sons of mothers who had smoked during 
pregnancy, there were small increases of both systolic and diastolic blood pressure. 
Further, there was also a dose-response relationship where the influence was largest in 
sons of heavy smokers. Within full brother pairs, where one brother had been exposed 
to maternal smoking in utero and the other had not, there was a tendency to higher 
blood pressure in the exposed brother. However, the results from the within-brother 
comparison were not statistically significant.  
 
Previous studies of maternal smoking during pregnancy and offspring blood pressure 
have yielded mixed results. Half of the published studies have shown a positive 
association [87,156-162]. Reported regression coefficients have been in the range from 
0.6 to 5.4. Capul-Uicab et al. investigated the association between in utero exposure to 
maternal smoking and subsequent hypertension, obesity and gestational diabetes among 
70 000 Norwegian women aged 14 - 47 [87]. They found an almost 70% increase in 
odds of hypertension also after adjustments for age, education, personal smoking and 
BMI. However, the authors also concluded that effects of unmeasured confounding 
could not be excluded. The other half of the previously published studies have reported 
null associations for smoking during pregnancy and offspring blood pressure, or 
associations that disappeared after adjustment for potential confounders [69,163-170]. 
Brion et al. reported similar influences of maternal and paternal smoking during 
pregnancy. After further adjustments for social factors these associations decreased 
towards the null [167]. In a study including 8815 participants aged 45 years, increases 
in blood pressure, BMI, waist circumference, HbA1c (a marker for hyperglycaemia), 
and triglycerides (blood lipids) were reported in those who had  been exposed to 
maternal smoking in utero [69]. However, after adjustments for postnatal influences, 
only associations with BMI and waist circumference remained significant.  
 
As seen, the findings are conflicting and postnatal influences such as the obesity 
epidemic are likely to have much larger public health implications. However, as seen in 
studies on low birth weight, the association with hypertension can be substantial despite 
very modest increases in blood pressure [56].  A recent review concludes that there is 
an accumulating body of evidence for an association between intrauterine exposure to 
smoking and later cardiovascular disease, diabetes type 2 and obesity [62]. Smoking 
during pregnancy is hypothesized to increase offspring blood pressure, at least partly, 
through IUGR which has been linked to increased arterial resistance, endothelial 
dysfunction, altered renal and cardiac structure and function, and altered composition 
and amount of perivascular adipose tissue [62,67,168,171]. Maternal smoking during 
pregnancy has also been associated with increased carotid intima-media thickness, a 
marker for atherosclerosis [171].  
 
Further studies are needed to determine if there is an association between maternal 
smoking during pregnancy and offspring blood pressure, hypertension and 
cardiovascular disease. These studies will also need to carefully address aetiology and 
confounding factors.  
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Intergenerational social mobility and the risk of hypertension  
Study III shows that upward social mobility is associated with decreased risk of 
hypertension compared to the stable low group, and suggests that downward social 
mobility is associated with increased risk compared to the stable high group. Parental 
socio-economic status (SES) was associated with increased hypertension risk in both 
men and women, while adult SES only was associated with hypertension in women. 
This suggests that social differences in hypertension risk are initiated early in life, but 
that they are modifiable. 
 
There is a well-known social gradient in the risks of hypertension and cardiovascular 
disease [9]. Both parental/childhood SES and adult SES have been associated with 
hypertension and cardiovascular disease [172-174]. A stronger social gradient in 
hypertension among women vs. men has been suggested to be due to a stronger social 
gradient in BMI among women [175,176]. In Study III, effects of BMI was adjusted 
for. However, to avoid possible influence of reverse causation, information on potential 
confounders were collected long before the outcome was measured. As BMI and other 
potential confounders can change over time, residual confounding is an issue. Although 
not all studies have reported an association between social mobility and hypertension 
[177], the findings from Study III are consistent with several previous reports. James et 
al found that, compared to the stable high SES group, the upward mobile group had a 
four  times greater risk of hypertension, the downward mobile group had a six fold 
increased risk and the stable low SES group had seven fold increased risk [178]. 
Waitzman and Smith reported an increased risk of hypertension in the downward 
mobile group [179]. Krieger et al investigated blood pressure levels in twin sisters and 
showed that the working class twin on average had 4.5 mm Hg higher systolic blood 
pressure than her twin sister with higher SES [180].  
 
The reason to why low SES is associated with hypertension risk is most likely 
multifactorial and operates over the life course. The social differences in health is to a 
large extent attributed to social differences in determinants of health, such as smoking, 
physical inactivity, poor diet and obesity [9]. Up to 90% of the absolute social 
differences in myocardial infarction have been attributed to the conventional risk 
factors [181]. Lynch et al. have demonstrated a paradox where conventional risk factors 
explain the majority of absolute social inequity, but only a modest part of the relative 
differences [101].  However, they conclude that if the aim is to reduce both the overall 
population burden of coronary heart disease and the disproportionate higher burden in 
some groups, reducing conventional risk factors “will do the job” [101].   
 
The social gradient in hypertension is one example of social inequity in health. Further, 
it is a cause of the social gradient in cardiovascular disease. Decreasing social gradients 
in health is a stated goal for both WHO and Swedish politicians. Possible ways to 
decrease the differences in health could be through interventions targeting special high 
risk groups, through improved health in the whole population and through a larger 
improvement in the least affluent groups [9]. Suggested aims have a clear life course 
approach; a good start in life for all children, good schooling, good possibilities to get a 
job, good working conditions, healthy minimal living standards etc. [9]. Special taxes 
and ban on smoking in public environments have also been used to improve public 
health. 
   47 
Intergenerational influence of birth size - genes or environment?  
Study IV, suggests that the intergenerational association in size at birth is due to direct 
or indirect genetic factors. We found an intergenerational association of size at birth 
among both dizygotic and monozygotic twin mothers and their offspring. Within 
dizygotic twin pairs, this association remained. That is, the offspring of the larger twin 
sister at birth was on average larger at birth than the offspring of the smaller twin sister. 
Within monozygotic twin pairs, there were no differences in birth size between the 
sister‟s children.  
 
There are several previous studies that have demonstrated an association between 
parent‟s and offspring‟s birth weights [19,23,182-191]. Usually, the association 
between mother and offspring have been stronger than between father and offspring 
[182,185,186,191], although, one study from India have reported the opposite finding 
[190]. A one hundred gram increase in mother‟s birth weight has been estimated to 
increase offspring birth weight with around 17-27 g [182,185,191] and the 
corresponding estimate for a one hundred gram increase in father birth weight have 
been around 9-14 g [182,185,191]. One previous study has reported birth weights in 
offspring of monozygotic twin pair mothers, who themselves had been discordant in 
birth weight [192]. They found no differences in offspring birth size within twin pairs.  
Nordtveit et al. investigated if the mother‟s birth order influenced her offspring‟s size at 
birth [193]. First born infants are usually lighter at birth than their subsequent siblings. 
Given the intergenerational association in size at birth, it could be hypothesized that 
those first born would have smaller children than those with higher birth order.  
However, the authors found that offspring of first born mothers actually were larger at 
birth than offspring of later born mothers. These differences were entirely explained by 
socio-economic factors. Furthermore, De Stavola et al. have shown that socio-
demographic and behavioural factors moderately, but significantly contribute to the 
intergenerational correlation in birth size [194].   
 
Birth weight is determined by many different factors and largely influenced by both 
genes and environment. Furthermore, genes and environment can be correlated. Genes 
that promote rapid growth can, for example, be present in both the mother and the 
foetus (as they are related) and directly influence growth. Genetic factors can also have 
caused the high birth weight of the mother and her large adult body size. As the 
mother‟s adult height and weight are determinants of offspring birth weight [19], these 
genes can hence promote foetal growth indirectly through the larger body size of the 
mother. A study of birth weight after ovum donations support an indirect influence, as 
they found that the size of the infant was correlated with the weight of the woman 
carrying the pregnancy and not the size of the genetic mother [195].  
 
Genetic, environmental and social factors all contribute to the intergenerational 
association in size at birth. However, when genetic and, to a large extent, 
environmental and social factors were held constant (monozygotic twin pairs) no 
influence of mother‟s birth size was seen on offspring‟s birth size. To understand the 
intergenerational influence of birth weight is of interest in the light of the DOHaD 
hypothesis.  
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7 CONCLUSIONS 
 
 Smoking during pregnancy is likely to be causally associated with stillbirth. 
Primary prevention of smoking is important, as it targets young people who 
are the future parents, before they develop nicotine dependence. Pregnant 
women who smoke should receive information about the risks and 
encouragement and support to quit. 
 
 Smoking during pregnancy may increase offspring blood pressure in late 
adolescence. Further studies, which carefully addresses confounding, are 
needed to investigate if this influence remains later in adulthood and if 
prenatal exposure to smoking increases the risk of hypertension or 
cardiovascular disease.  
 
 Low socio-economic status in childhood is associated with increased risk of 
hypertension in middle age. This risk can be modified by adult socio-
economic status. This suggests that social differences in hypertension start 
early, but also that the risk is modifiable.   
 
 The intergenerational association between mother‟s and offspring‟s size at 
birth is suggested to be due to direct or indirect genetic factors.  
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8 FUTURE CHALLENGES 
The negative effects of maternal smoking during pregnancy on several obstetrical and 
perinatal outcomes have been well documented [5]. The risks are generally also known 
to the public, at least in western countries [196]. Most women who quit smoking during 
pregnancy do so because of concern for the foetus [58]. There are also many women 
who want to quit, but fail in doing so. Lumley et al. have reported that up to 45% of 
pregnant women stop smoking spontaneously in early pregnancy, however 21% of 
them relapse already before delivery and only one third of  spontaneous quitters are still 
abstinent after one year [63]. Smoking is declining in western countries, but still 
increasing in many other populations. WHO has pointed out increased smoking among 
women in low and middle income countries as one of the most worrying developments 
in the tobacco epidemic [197].  
 
Although maternal smoking during pregnancy has decreased steadily in Sweden since 
the 1970‟s, there are still subgroups where the prevalence is high, for example among 
teenage mothers and among low educated women. In 2006, there were still 
municipalities with a smoking prevalence in early pregnancy of 20-30% while other 
areas had a prevalence of 0-2% [57]. Interventions for smoking cessation during 
pregnancy were evaluated in a Cochrane review in 2009 [63]. Pooled data from 65 
clinical trials showed a reduction in smoking during late pregnancy of 6% in the 
intervention group compared to the control group (relative risk with 95% confidence 
interval: 0.94 (0.93-0.96). Further, there was a 17% reduction in the risk of low birth 
weight, a 14% reduction in the risk of preterm birth and weighted mean birth weight 
increased with 53 grams [63]. The authors of the Cochrane review conclude that 
attention to smoking behaviour and support for smoking cessation and relapse 
prevention should be a routine part of all antenatal care.  
 
Nicotine is an addictive substance. Many pregnant women find it very difficult to quit 
smoking even though they want to and many women relapse. One very important risk 
factor for continued smoking during pregnancy is having a partner who smokes [61]. 
Therefore, primary prevention strategies in the whole community are also very 
important for obstetric outcomes and neonatal health. Most important is to reduce 
smoking initiation among young people who are the future parents. Strategies to reduce 
smoking outlined by the WHO have been prohibition of smoking in public places, 
increased taxation on tobacco products, preventing sales of tobacco products to young 
people, bans on tobacco sponsorship of prestigious events and warning texts and 
pictures on cigarette packages [197]. Advantageous effects of introducing public 
smoking bans have been shown. In a study from Colorado preterm births decreased by 
23% the year after the smoking ban was introduced [198]. In Scotland, the prevalence 
of smoking in pregnancy decreased from 25% to 19% and the preterm deliveries 
decreased by 12% after the smoking ban was introduced [199].   
 
As we have seen, smoking during pregnancy is strongly related to socio-economic 
status and also to psychological factors such as stress and depression [63]. A future 
challenge is to develop better intervention programs and especially to find ways to help 
women in these groups. From a public health perspective, smoking and overweight 
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have been pointed out as the most important modifiable risk factors for pregnancy 
complications and adverse pregnancy outcomes [58].  
 
More research is needed to determine whether maternal smoking during pregnancy has 
a long term influence on offspring health. Results from some human and animal studies 
suggest that there is an association [62,67]. However, the influence of socio-economic 
and familial confounding could be substantial. If maternal smoking during pregnancy 
can be shown to have long time influences on later health this will raise the question of 
whether early interventions should be implemented in this group.  
 
Differences in smoking habits and to some extent differences in overweight/obesity 
have also been suggested to explain a substantial part of the social gradient in health 
[9,200]. To decrease social inequity in health is a worldwide challenge [201]. 
Suggested ways to achieve this have for example been to improve health in the whole 
population and especially target deprived groups. The importance of a life course 
approach is clear in the given suggestions; to give all children a good start in life which 
requires good maternal nutrition, antenatal and child care, to provide good schooling, 
fair and decent working conditions, healthy housing and communities, social protection 
throughout life and universal health care [9,202].  
 
At present, intrauterine growth restriction is managed by determining aetiology and 
severity of the growth restriction and selecting time and mode of delivery [12]. There 
have been several attempts to prevent and treat growth restricted foetuses in utero, for 
example through low dose aspirin treatment, maternal oxygen therapy, maternal 
nutritional supplementation and plasma volume expansion [10,21,203]. Some of these 
interventions, such as low dose aspirin in preventing preeclampsia and intrauterine 
growth restriction have reported positive results [204]. However, further research on 
treatment of foetal growth restriction is needed. Considering the many aetiologies, it is 
unlikely that one intervention will be suitable to all patients.  
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9 SVENSK SAMMANFATTNING  
Avhandlingens syfte 
Under fostertiden genomgår vi vår allra största utveckling. På omkring fyrtio veckor 
blir en enda cell ett fullt utvecklat barn. Det är lätt att tänka sig att faktorer under denna 
tid, då alla organ och vävnader bildas, kan påverka hälsan på lång sikt, kanske under 
resten av livet. Denna avhandling, som består av fyra vetenskapliga studier, handlar om 
just sådana tidiga exponeringar och deras effekter på hälsan. Fokus ligger på moderns 
rökning under graviditet, födelsevikt och social status. De specifika frågeställningarna 
har varit följande: 
 
 Förändras risken att föda ett dödfött barn om modern ändrar sina rökvanor 
mellan två graviditeter? Om förändring av exponering för rökning medför en 
förändrad risk för dödföddhet stöder detta ett orsakssamband mellan rökning 
under graviditet och dödföddhet. 
 Påverkar moderns rökning under graviditeten avkommans blodtryck i 
tonåren? 
 Förändrar de som gör en social klassresa även sin risk att drabbas av högt 
blodtryck? 
 Får den större tvillingsystern i ett likkönat tvillingpar med olika födelsevikt, i 
sin tur barn som är större än den mindre tvillingsysterns barn? Eller förklaras 
sambandet mellan mor och barns födelsevikter av delad genetik/miljö? 
Registerbaserade studier 
I Sverige finns det ett flertal rikstäckande register, som dessutom kan sammanlänkas 
via personnumren. Detta sker i anonymiserad form och regleras av lagar som värnar 
människors integritet. Till exempel måste studier som använder sig av registerdata först 
godkännas av en etisk kommitté. Denna avhandling bygger på information från 
framförallt Medicinska födelseregistret, Värnpliktsregistret och Svenska 
Tvillingregistret.  
Sammanfattning av delarbetena 
Delarbete I: Moderns rökning och risken att få ett dödfött barn 
I denna studie undersöktes moderns rökning under graviditeten som en möjlig orsak till 
att fostret dör i livmodern. Studiepopulationen innefattade alla kvinnor som födde sina 
två första barn i Sverige mellan 1983 och 2001. Informationen om kvinnornas rökning 
tidigt i graviditeten var självrapporterad och kom från mödravårdsjournaler. 
Definitionen på dödfödd var barn födda utan livstecken efter graviditetsvecka 28. 
Resultaten visade att de mödrar som rökte under graviditeten i högre grad riskerade att 
få dödfödda barn jämfört med icke-rökarna. De kvinnor som rökte mer (10 cigaretter 
eller mer per dag) löpte en större risk än de som rökte mindre (1-9 cigaretter per dag). 
Hos kvinnor som slutade röka mellan två graviditeter förelåg ingen ökad risk för att 
barnet skulle dö i livmodern i den andra graviditeten (då de var icke rökare). För 
kvinnor som rökte i en av sina två graviditeter var risken att föda ett dödfött barn 
fördubblad i den graviditet där hon rökte (10 cigaretter eller mer per dag) jämfört med 
den i vilken hon inte gjorde det.  
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Delarbete II: Moderns rökning och påverkan på avkommans blodtryck 
I denna studie undersöktes om moderns rökning under graviditeten hade någon 
påverkan på tonårssöners (18 år i genomsnitt) blodtryck. Studiepopulationen bestod av  
män födda i Sverige mellan 1983 och 1988, som mönstrade mellan 2001 och 2006. 
Resultaten visade en mycket liten men statistiskt signifikant ökning av blodtrycket 
(både över- och undertrycket) hos söner till mödrar som rökt under graviditeten. Denna 
ökning var störst hos de vars mor hade rökt mest. Samma tendens sågs mellan 
brödrapar. Det vill säga, brodern som hade exponerats för moderns rökning i livmodern 
verkade ha något högre blodtryck än brodern som inte hade exponerats. Detta resultat 
kunde dock inte statistiskt säkerställas.  
Delarbete III: Social mobilitet över två generationer och högt blodtryck 
I denna studie undersöktes om en klassresa mellan föräldrars socialgrupp och egen 
socialgrupp i vuxen ålder förändrade risken för högt blodtryck. Studiepopulationen 
bestod av likkönade tvillingar födda i Sverige mellan 1926 och 1958. Information om 
yrke användes som indikator för socialgrupp. Tvillingarna delades in i låg status 
(facklärd och icke-facklärd arbetare samt tjänsteman på låg nivå) och hög status 
(tjänsteman på mellan eller hög nivå). Den sociala mobiliteten - eller klassresan - 
definierades som byte av social status jämfört med den status föräldrarna hade haft. 
Resultaten visade att låg social status som vuxen var kopplat till högt blodtryck hos 
kvinnor, men inte hos män. Att ha haft föräldrar med låg social status var dock kopplat 
till 40% högre risk för högt blodtryck hos både män och kvinnor, jämfört med dem som 
hade haft föräldrar med hög social status. De som gjort en klassresa från låg till hög 
social status hade 20% lägre risk för högt blodtryck jämfört med de som stannat i 
gruppen med lägre social status. De som gjort en omvänd klassresa - från hög till låg 
social status - hade en tendens till ökad risk för högt blodtryck. I jämförelsen inom 
tvillingpar, där bara den ena tvillingen hade gjort en klassresa uppåt, sågs samma 
tendens till minskad risk för högt blodtryck hos den tvilling som klättrat jämfört med 
den som inte hade gjort det. Den statistiska säkerheten i analyserna påverkas emellertid 
av att endast få tvillingpar där bara ena gjort en klassresa kunde identifieras.  
Delarbete IV: Sambandet mellan mor och barns födelsevikt – gener eller miljö? 
I denna studie undersöktes om skillnaden i födelsevikt hos kvinnliga tvillingpar 
upprepades då de själva fick barn. Det vill säga, fick den vid födelsen större tvillingen 
större barn än hennes mindre tvillingsyster? Studiepopulationen bestod av kvinnliga 
tvillingar - födda i Sverige mellan 1926 och 1985 - vilka födde sitt första barn mellan 
1973 och 2009.  
Resultaten visade att de mödrar som hade varit tyngre och längre vid födseln själva fick 
större barn. Sambandet fanns kvar inom tvåäggstvillingpar, men försvann inom 
enäggstvillingarpar. Sambandet försvann alltså inom de par där mödrarna hade samma 
gener.  
 
 
 
 
 
 
 
   53 
 
Slutsatser 
 Om kvinnan slutar röka, innan eller mycket tidigt i graviditeten, reduceras 
risken till samma nivå som den för kvinnor, vilka aldrig rökt under en 
graviditet. Dessa resultat stöder hypotesen att rökning kan orsaka dödföddhet.  
 
 Rökning under graviditeten kan eventuellt höja avkommans blodtryck ända 
upp i tonåren. Huruvida sambandet kvarstår även senare i vuxenlivet och om 
detta medför en ökad sårbarhet för högt blodtryck och hjärt-kärlsjukdom 
behöver studeras ytterligare.  
 
 Uppväxten i ett hem med låg social status (föräldrarnas status) är kopplad till 
en ökad risk för högt blodtryck. Denna risk kan dock modifieras via social 
status som vuxen. Detta visar att sambandet mellan låg social status och risk 
för högt blodtryck grundläggs tidigt, men också att effekten är påverkbar.  
 
 Sambandet mellan mor och barns födelsevikter förklaras av gemensamma 
genetiska faktorer. Dessa kan antingen verka direkt genom att mor och barn 
till viss del delar samma gener, eller indirekt, genom att mammans gener 
påverkar hennes fysiologi (t.ex. hennes längd och vikt som vuxen), vilken i 
sin tur påverkar barnets miljö och tillväxt i livmodern.    
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